Caleres (CAL) 10-Q 7 Dec 21 2021 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Oct. 30, 2021	Nov. 26, 2021
Document And Entity Information
Entity Central Index Key	0000014707
Entity Registrant Name	CALERES, INC
Amendment Flag	false
Current Fiscal Year End Date	--01-29
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2021
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 30, 2021
Document Transition Report	false
Entity File Number	1-2191
Entity Incorporation, State or Country Code	NY
Entity Tax Identification Number	43-0197190
Entity Address, Address Line One	8300 Maryland Avenue
Entity Address, City or Town	St. Louis
Entity Address, State or Province	MO
Entity Address, Postal Zip Code	63105
City Area Code	314
Local Phone Number	854-4000
Title of 12(b) Security	Common Stock - par value of $0.01 per share
Trading Symbol	CAL
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		38,089,914

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Oct. 30, 2021	Jan. 30, 2021	Oct. 31, 2020
Current assets:
Cash and cash equivalents	$ 74,772	$ 88,295	$ 124,330
Receivables, net	161,892	126,994	141,059
Inventories, net	543,218	487,955	507,365
Income taxes	35,026	33,925	53,888
Prepaid expenses and other current assets	47,790	45,387	45,513
Total current assets	862,698	782,556	872,155
Prepaid pension costs	96,705	88,833	59,267
Lease right-of-use assets	500,308	554,303	601,574
Property and equipment, net	155,516	172,437	189,207
Deferred income taxes	0	0	9,456
Goodwill and intangible assets, net	230,625	240,071	267,074
Other assets	28,706	28,850	28,327
Total assets	1,874,558	1,867,050	2,027,060
Current liabilities:
Borrowings under revolving credit agreement	175,000	250,000	300,000
Mandatory purchase obligation - Blowfish Malibu	54,558	39,134	30,146
Current portion of long-term debt	99,598	0	0
Trade accounts payable	352,084	280,501	285,582
Income taxes	22,371	5,069	7,053
Lease obligations	128,151	153,060	156,200
Other accrued expenses	238,298	177,745	180,927
Total current liabilities	1,070,060	905,509	959,908
Other liabilities:
Noncurrent lease obligations	452,786	518,942	556,343
Long-term debt	0	198,851	198,736
Income taxes	2,464	5,038	7,786
Deferred income taxes	13,603	8,244	12,944
Other liabilities	29,900	26,612	29,688
Total other liabilities	498,753	757,687	805,497
Equity:
Common stock	383	380	379
Additional paid-in capital	165,475	160,446	159,327
Accumulated other comprehensive loss	(8,471)	(9,136)	(31,184)
Retained earnings	143,711	48,557	128,149
Total Caleres, Inc. shareholders' equity	301,098	200,247	256,671
Noncontrolling interests	4,647	3,607	4,984
Total equity	305,745	203,854	261,655
Total liabilities and equity	$ 1,874,558	$ 1,867,050	$ 2,027,060

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (LOSS) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (LOSS)
Net sales	$ 784,156	$ 647,480	$ 2,098,323	$ 1,546,111
Cost of goods sold	448,805	390,508	1,165,792	984,621
Gross profit	335,351	256,972	932,531	561,490
Selling and administrative expenses	254,033	236,901	757,070	663,425
Impairment of goodwill and intangible assets	0	0	0	262,719
Restructuring and other special charges, net	0	0	13,482	65,625
Operating earnings (loss)	81,318	20,071	161,979	(430,279)
Interest expense, net	(5,069)	(10,881)	(28,803)	(33,747)
Loss on early extinguishment of debt	(649)	0	(649)	0
Other income, net	3,844	5,461	11,533	12,718
Earnings (loss) before income taxes	79,444	14,651	144,060	(451,308)
Income tax (provision) benefit	(19,759)	275	(39,838)	89,393
Net earnings (loss)	59,685	14,926	104,222	(361,915)
Net earnings attributable to noncontrolling interests	63	509	1,057	223
Net earnings (loss) attributable to Caleres, Inc.	$ 59,622	$ 14,417	$ 103,165	$ (362,138)
Basic earnings (loss) per common share attributable to Caleres, Inc. shareholders	$ 1.56	$ 0.38	$ 2.70	$ (9.67)
Diluted earnings (loss) per common share attributable to Caleres, Inc. shareholders	$ 1.54	$ 0.38	$ 2.68	$ (9.67)

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
Net earnings (loss)	$ 59,685	$ 14,926	$ 104,222	$ (361,915)
Other comprehensive income (loss) ("OCI"), net of tax:
Foreign currency translation adjustment	(267)	401	(423)	(409)
Pension and other postretirement benefits adjustments	358	(67)	1,071	1,057
Derivative financial instruments	0	0	0	92
Other comprehensive income, net of tax	91	334	648	740
Comprehensive income (loss)	59,776	15,260	104,870	(361,175)
Comprehensive income attributable to noncontrolling interests	53	590	1,040	304
Comprehensive income (loss) attributable to Caleres, Inc.	$ 59,723	$ 14,670	$ 103,830	$ (361,479)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020
Operating Activities
Net earnings (loss)	$ 104,222	$ (361,915)
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:
Depreciation	25,617	31,923
Amortization of capitalized software	4,417	4,410
Amortization of intangible assets	9,446	9,786
Amortization of debt issuance costs and debt discount	732	1,016
Fair value adjustments to Blowfish mandatory purchase obligation	15,424	14,946
Loss on early extinguishment of debt	649	0
Share-based compensation expense	8,811	6,920
Loss on disposal of property and equipment	640	848
Impairment charges for property, equipment, and lease right-of-use assets	3,399	35,620
Impairment of goodwill and intangible assets	0	262,719
Provision/adjustment for expected credit losses	(2,711)	10,663
Deferred income taxes	5,359	(41,790)
Changes in operating assets and liabilities:
Receivables	(32,188)	8,313
Inventories	(54,917)	110,954
Prepaid expenses and other current and noncurrent assets	(9,056)	(18,510)
Trade accounts payable	71,468	18,592
Accrued expenses and other liabilities	25,972	55,345
Income taxes, net	13,627	(47,833)
Other, net	(1,183)	(241)
Net cash provided by operating activities	189,728	101,766
Investing Activities
Purchases of property and equipment	(10,437)	(12,016)
Capitalized software	(4,122)	(3,525)
Net cash used for investing activities	(14,559)	(15,541)
Financing Activities
Borrowings under revolving credit agreement	363,000	340,500
Repayments under revolving credit agreement	(438,000)	(315,500)
Redemption of senior notes	(100,000)	0
Dividends paid	(8,011)	(8,148)
Debt issuance costs	(1,190)	0
Acquisition of treasury stock	0	(23,348)
Issuance of common stock under share-based plans, net	(3,779)	(1,078)
Contributions by noncontrolling interests, net	0	1,500
Other	(676)	(980)
Net cash used for financing activities	(188,656)	(7,054)
Effect of exchange rate changes on cash and cash equivalents	(36)	(59)
(Decrease) increase in cash and cash equivalents	(13,523)	79,112
Cash and cash equivalents at beginning of period	88,295	45,218
Cash and cash equivalents at end of period	$ 74,772	$ 124,330

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Cumulative effect adjustmentRetained Earnings	Cumulative effect adjustmentCaleres, Inc.	Cumulative effect adjustment	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive (Loss) Income	Retained Earnings	Caleres, Inc.	Non-controlling Interest	Total
BALANCE at Feb. 01, 2020				$ 404	$ 153,489	$ (31,843)	$ 523,900	$ 645,950	$ 3,180	$ 649,130
BALANCE (in shares) at Feb. 01, 2020				40,396,757
Net earnings (loss)							(362,138)	(362,138)	223	(361,915)
Foreign currency translation adjustment						(490)		(490)	81	(409)
Unrealized gain (loss) on derivative financial instruments, net of tax						92		92		92
Pension and other postretirement benefits adjustments						1,057		1,057		1,057
Comprehensive income (loss)						659	(362,138)	(361,479)	304	(361,175)
Contributions by noncontrolling interests									1,500	1,500
Dividends							(8,148)	(8,148)		(8,148)
Acquisition of treasury stock				$ (29)			(23,319)	(23,348)		(23,348)
Acquisition of treasury stock (in shares)				(2,902,122)
Issuance of common stock under share-based plans, net				$ 4	(1,082)			(1,078)		(1,078)
Issuance of common stock under share-based plans, net (in shares)				449,539
Share-based compensation expense					6,920			6,920		6,920
BALANCE at Oct. 31, 2020				$ 379	159,327	(31,184)	128,149	256,671	4,984	261,655
BALANCE (in shares) at Oct. 31, 2020				37,944,174
BALANCE at Aug. 01, 2020				$ 379	156,913	(31,437)	116,385	242,240	2,894	245,134
BALANCE (in shares) at Aug. 01, 2020				37,912,156
Net earnings (loss)							14,417	14,417	509	14,926
Foreign currency translation adjustment						320		320	81	401
Unrealized gain (loss) on derivative financial instruments, net of tax										0
Pension and other postretirement benefits adjustments						(67)		(67)		(67)
Comprehensive income (loss)						253	14,417	14,670	590	15,260
Contributions by noncontrolling interests									1,500	1,500
Dividends							(2,653)	(2,653)		(2,653)
Acquisition of treasury stock								0
Issuance of common stock under share-based plans, net				$ 0	(104)			(104)		(104)
Issuance of common stock under share-based plans, net (in shares)				32,018
Share-based compensation expense					2,518			2,518		2,518
BALANCE at Oct. 31, 2020				$ 379	159,327	(31,184)	128,149	256,671	4,984	261,655
BALANCE (in shares) at Oct. 31, 2020				37,944,174
BALANCE (Accounting Standards Update 2016-13 (ASC 326)) at Jan. 30, 2021	$ (2,146)	$ (2,146)	$ (2,146)
BALANCE at Jan. 30, 2021				$ 380	160,446	(9,136)	48,557	200,247	3,607	203,854
BALANCE (in shares) at Jan. 30, 2021				37,966,204
Net earnings (loss)							103,165	103,165	1,057	104,222
Foreign currency translation adjustment						(406)		(406)	(17)	(423)
Unrealized gain (loss) on derivative financial instruments, net of tax										0
Pension and other postretirement benefits adjustments						1,071		1,071		1,071
Comprehensive income (loss)						665	103,165	103,830	1,040	104,870
Dividends							(8,011)	(8,011)		(8,011)
Issuance of common stock under share-based plans, net				$ 3	(3,782)			(3,779)		(3,779)
Issuance of common stock under share-based plans, net (in shares)				291,306
Share-based compensation expense					8,811			8,811		8,811
BALANCE at Oct. 30, 2021				$ 383	165,475	(8,471)	143,711	301,098	4,647	305,745
BALANCE (in shares) at Oct. 30, 2021				38,257,510
BALANCE at Jul. 31, 2021				$ 383	162,122	(8,572)	86,764	240,697	4,594	245,291
BALANCE (in shares) at Jul. 31, 2021				38,268,064
Net earnings (loss)							59,622	59,622	63	59,685
Foreign currency translation adjustment						(257)		(257)	(10)	(267)
Unrealized gain (loss) on derivative financial instruments, net of tax										0
Pension and other postretirement benefits adjustments						358		358		358
Comprehensive income (loss)						101	59,622	59,723	53	59,776
Dividends							(2,675)	(2,675)		(2,675)
Issuance of common stock under share-based plans, net				$ 0	(27)			(27)		(27)
Issuance of common stock under share-based plans, net (in shares)				(10,554)
Share-based compensation expense					3,380			3,380		3,380
BALANCE at Oct. 30, 2021				$ 383	$ 165,475	$ (8,471)	$ 143,711	$ 301,098	$ 4,647	$ 305,745
BALANCE (in shares) at Oct. 30, 2021				38,257,510

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Parentheticals) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
Pension and other postretirement benefits adjustments, tax	$ 87	$ 44	$ 269	$ 336
Dividends, per share (in dollars per share)	$ 0.07	$ 0.07	$ 0.21	$ 0.21
Unrealized gain (loss) on derivative financial instruments, tax				$ 31

Basis of Presentation and Gener

Basis of Presentation and General	9 Months Ended
	Oct. 30, 2021
Basis of Presentation and General
Basis of Presentation and General	Note 1 Basis of Presentation and General Basis of Presentation The accompanying condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q of the United States Securities and Exchange Commission (“SEC”) and reflect all adjustments and accruals of a normal recurring nature, which management believes are necessary to present fairly the financial position, results of operations, comprehensive income and cash flows of Caleres, Inc. ("the Company"). These statements, however, do not include all information and footnotes necessary for a complete presentation of the Company’s consolidated financial position, results of operations, comprehensive income and cash flows in conformity with accounting principles generally accepted in the United States. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries, after the elimination of intercompany accounts and transactions. ​ The Company’s business is seasonal in nature due to consumer spending patterns, with higher back-to-school and holiday season sales. Traditionally, the third fiscal quarter accounts for a substantial portion of the Company’s earnings for the year. Interim results may not necessarily be indicative of results which may be expected for any other interim period or for the year as a whole. Certain prior period amounts in the condensed consolidated financial statements and footnotes have been reclassified to conform to the current period presentation. These reclassifications did not affect net earnings (loss) attributable to Caleres, Inc. The accompanying condensed consolidated financial statements and footnotes should be read in conjunction with the consolidated financial statements and footnotes included in the Company’s Annual Report on Form 10-K for the year ended January 30, 2021. Noncontrolling Interests During 2019, the Company entered into a joint venture with Brand Investment Holding Limited (“Brand Investment Holding”), a member of the Gemkell Group. The Company and Brand Investment Holding are each 50% owners of the joint venture, which is named CLT Brand Solutions (“CLT”). Net sales and operating earnings were $4.7 million and $0.2 million, respectively, for the thirteen weeks and $14.5 million and $2.4 million, respectively, for the thirty-nine weeks ended October 30, 2021. Net sales and operating earnings were not significant during the thirteen or thirty-nine weeks ended October 31, 2020. The Company had a joint venture agreement with a subsidiary of C. banner International Holdings Limited (“CBI”) to market Naturalizer footwear in China. The Company was a 51% owner of the joint venture (“B&H Footwear”), with CBI owning the other 49%. The license enabling the joint venture to market the footwear expired in August 2017 and the parties are in the process of dissolving their joint venture agreements. The Company anticipates the liquidation to be completed during the fourth quarter of 2021. The Company consolidates CLT and B&H Footwear into its condensed consolidated financial statements. Net earnings (loss) attributable to noncontrolling interests represents the share of net earnings or losses that are attributable to Brand Investment Holding equity. Transactions between the Company and the joint ventures have been eliminated in the condensed consolidated financial statements. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. ​ Derivative Financial Instruments The Company’s hedging policy permits the use of forward contracts as cash flow hedging instruments to manage its currency exposures in foreign currency-denominated assets, liabilities and cash flows. These derivative financial instruments are viewed as risk management tools and are not used for trading or speculative purposes. The Company recognizes all derivative financial instruments as either assets or liabilities in the condensed consolidated balance sheets and measures those instruments at fair value. ​ COVID-19 Pandemic The coronavirus (“COVID-19”) pandemic had a significant adverse impact on the United States economy and the retail industry. The Company’s financial results were negatively impacted during the first half of 2020 as a result of the temporary closure of all retail stores beginning in mid-March. The Company experienced sequential improvement in sales in the second half of 2020, driven by the reopening of the retail stores, and continued solid growth of the e-commerce business. During the first half of 2021, as the vaccines became widely distributed and governments continued to ease restrictions, consumer sentiment and spending began to improve. In addition, the additional stimulus measures approved by the federal government provided a boost in consumer spending. These factors strengthened demand for our products, which contributed to higher store traffic and strong growth in the Company’s net sales and operating earnings for the thirty-nine weeks ended October 30, 2021. On March 27, 2020, the Coronavirus Aid, Relief and Economic Security ("CARES") Act was enacted. The CARES Act includes a provision that allows the Company to defer the employer portion of social security payroll tax payments that would have been paid between the enactment date and December 31, 2020, with 50% payable by December 31, 2021 and 50% payable by December 31, 2022. During 2020, the Company deferred approximately $9.4 million of employer social security payroll taxes. As of October 30, 2021, approximately $4.7 million is recorded in other accrued expenses and $4.7 million is recorded in other liabilities on the condensed consolidated balance sheet. As of October 31, 2020, approximately $7.0 million was recorded in other liabilities on the condensed consolidated balance sheet. Corporate Headquarters Campus In April 2021, the Company announced that it would begin marketing for sale its nine-acre corporate headquarters campus (the “Campus”) located in Clayton, Missouri. The Company continues to evaluate offers and explore relocation and redevelopment options. The Company does not anticipate the Campus to qualify as a completed sale within the next twelve months. Accordingly, as of October 30, 2021, the Campus is considered held and used and classified within property and equipment, net on the condensed consolidated balance sheets. In addition, the Company evaluated the Campus asset group for impairment indicators and determined that no indicators were present.

Impact of New Accounting Pronou

Impact of New Accounting Pronouncements	9 Months Ended
	Oct. 30, 2021
Impact of New Accounting Pronouncements
Impact of New Accounting Pronouncements	Note 2 Impact of New Accounting Pronouncements Impact of Recently Adopted Accounting Pronouncements In August 2018, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2018-14, Compensation — Retirement Benefits — Defined Benefit Plans — General (Subtopic 715-20), Disclosure Framework — Changes to the Disclosure Requirements for Defined Benefit Plans In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes ​ Impact of Prospective Accounting Pronouncements In November 2020, the SEC issued SEC Release No. 33-10890, Management’s Discussion and Analysis, Selected Financial Data and Supplementary Financial Information ​

Revenues

Revenues	9 Months Ended
	Oct. 30, 2021
Revenues
Revenues	Note 3 Revenues Disaggregation of Revenues The following table disaggregates revenue by segment and major source for the periods ended October 30, 2021 and October 31, 2020: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirteen Weeks Ended October 30, 2021 ​ ​ ​ ​ ​ ​ ​ ​ Eliminations and ​ ​ ​ ($ thousands) Famous Footwear Brand Portfolio Other Total ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Retail stores ​ $ 429,914 ​ $ 17,230 ​ $ — ​ $ 447,144 Landed wholesale - e-commerce - drop ship (1) ​ — ​ 22,054 ​ (644) ​ 21,410 E-commerce - Company websites (1) ​ 63,964 ​ 44,101 ​ — ​ 108,065 Total direct-to-consumer sales ​ ​ 493,878 ​ ​ 83,385 ​ ​ (644) ​ ​ 576,619 First-cost wholesale - e-commerce (1) ​ — ​ 567 ​ — ​ 567 Landed wholesale - e-commerce (1) ​ ​ — ​ ​ 46,842 ​ ​ — ​ ​ 46,842 Landed wholesale - other ​ — ​ 138,813 ​ (10,373) ​ 128,440 First-cost wholesale ​ — ​ 27,315 ​ — ​ 27,315 Licensing and royalty ​ 602 ​ 3,536 ​ — ​ 4,138 Other (2) ​ 180 ​ 55 ​ — ​ 235 Net sales ​ $ 494,660 ​ $ 300,513 ​ $ (11,017) ​ $ 784,156 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirteen Weeks Ended October 31, 2020 ​ ​ ​ ​ ​ ​ ​ ​ Eliminations and ​ ​ ​ ($ thousands) Famous Footwear Brand Portfolio Other Total ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Retail stores ​ $ 325,501 ​ $ 14,291 ​ $ — ​ $ 339,792 Landed wholesale - e-commerce - drop ship (1) ​ ​ — ​ ​ 21,256 ​ ​ — ​ ​ 21,256 E-commerce - Company websites (1) ​ 66,058 ​ 35,100 ​ — ​ 101,158 Total direct-to-consumer sales ​ ​ 391,559 ​ ​ 70,647 ​ ​ — ​ ​ 462,206 First-cost wholesale - e-commerce (1) ​ — ​ 99 ​ — ​ 99 Landed wholesale - e-commerce (1) ​ — ​ 42,001 ​ — ​ 42,001 Landed wholesale - other ​ — ​ 136,627 ​ (11,813) ​ 124,814 First-cost wholesale ​ — ​ 15,368 ​ — ​ 15,368 Licensing and royalty ​ — ​ 2,809 ​ — ​ 2,809 Other (2) ​ 147 ​ 36 ​ — ​ 183 Net sales ​ $ 391,706 ​ $ 267,587 ​ $ (11,813) ​ $ 647,480 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirty-Nine Weeks Ended October 30, 2021 ​ ​ ​ ​ ​ ​ ​ ​ Eliminations and ​ ​ ​ ($ thousands) Famous Footwear Brand Portfolio Other Total ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Retail stores ​ $ 1,166,837 ​ $ 44,241 ​ $ — ​ $ 1,211,078 Landed wholesale - e-commerce - drop ship (1) ​ — ​ 62,529 ​ (1,477) ​ 61,052 E-commerce - Company websites (1) ​ 178,367 ​ 136,458 ​ — ​ 314,825 Total direct-to-consumer sales ​ $ 1,345,204 ​ $ 243,228 ​ $ (1,477) ​ $ 1,586,955 First-cost wholesale - e-commerce (1) ​ — ​ 2,340 ​ — ​ 2,340 Landed wholesale - e-commerce (1) ​ ​ — ​ ​ 114,608 ​ ​ — ​ ​ 114,608 Landed wholesale - other ​ — ​ 353,597 ​ (36,445) ​ 317,152 First-cost wholesale ​ — ​ 67,651 ​ — ​ 67,651 Licensing and royalty ​ 602 ​ 8,302 ​ — ​ 8,904 Other (2) ​ 607 ​ 106 ​ — ​ 713 Total net sales ​ $ 1,346,413 ​ $ 789,832 ​ $ (37,922) ​ $ 2,098,323 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirty-Nine Weeks Ended October 31, 2020 ​ ​ ​ ​ ​ ​ ​ ​ Eliminations and ​ ​ ​ ($ thousands) Famous Footwear Brand Portfolio Other Total ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Retail stores ​ $ 712,761 ​ $ 33,173 ​ $ — ​ $ 745,934 Landed wholesale - e-commerce - drop ship (1) ​ ​ — ​ ​ 61,235 ​ ​ — ​ ​ 61,235 E-commerce - Company websites (1) ​ 203,888 ​ 108,926 ​ — ​ 312,814 Total direct-to-consumer sales ​ $ 916,649 ​ $ 203,334 ​ $ — ​ $ 1,119,983 First-cost wholesale - e-commerce (1) ​ — ​ 601 ​ — ​ 601 Landed wholesale - e-commerce (1) ​ ​ — ​ ​ 91,477 ​ ​ — ​ ​ 91,477 Landed wholesale - other ​ — ​ 327,322 ​ (39,229) ​ 288,093 First-cost wholesale ​ — ​ 39,139 ​ — ​ 39,139 Licensing and royalty ​ — ​ 6,463 ​ — ​ 6,463 Other (2) ​ 244 ​ 111 ​ — ​ 355 Net sales ​ $ 916,893 ​ $ 668,447 ​ $ (39,229) ​ $ 1,546,111 (1) Collectively referred to as "e-commerce" below (2) Includes breakage revenue from unredeemed gift cards Retail stores Traditionally, the majority of the Company’s revenue is generated from retail sales where control is transferred and revenue is recognized at the point of sale. Retail sales are recorded net of estimated returns and exclude sales tax. The Company records a returns reserve and a corresponding return asset for expected returns of merchandise. Retail sales to members of the Company’s loyalty programs, including the Famously You Rewards program, include two performance obligations: the sale of merchandise and the delivery of points that may be redeemed for future purchases. The transaction price is allocated to the separate performance obligations based on the relative stand-alone selling price. The stand-alone selling price for the points is estimated using the retail value of the merchandise earned, adjusted for estimated breakage based upon historical redemption patterns. The revenue associated with the initial merchandise purchased is recognized immediately and the value assigned to the points is deferred until the points are redeemed, forfeited or expired. Landed wholesale Landed sales are wholesale sales in which the merchandise is shipped directly to the customer from the Company’s warehouses. Many customers purchasing footwear on a landed basis arrange their own transportation of merchandise and, with limited exceptions, control is transferred at the time of shipment. First-cost wholesale First-cost sales are wholesale sales in which the Company purchases merchandise from an international factory that manufactures the product and subsequently sells to a customer at an overseas port. Revenue is recognized at the time the merchandise is delivered to the customer’s designated freight forwarder and control is transferred to the customer. E-commerce The Company also generates revenue from sales on websites maintained by the Company that are shipped from the Company’s distribution centers or retail stores directly to the consumer, picked up directly by the consumer from the Company’s stores and e-commerce sales from the Company’s wholesale customers’ websites that are fulfilled on a drop-ship or first-cost basis (collectively referred to as "e-commerce"). The Company transfers control and recognizes revenue for merchandise sold that is shipped directly to an individual consumer upon delivery to the consumer. Licensing and royalty The Company has license agreements with third parties allowing them to sell the Company’s branded product, or other merchandise that uses the Company’s owned or licensed brand names. These license agreements provide the licensee access to the Company’s symbolic intellectual property, and revenue is therefore recognized over the license term. For royalty contracts that do not have guaranteed minimums, the Company recognizes revenue as the licensee’s sales occur. For royalty contracts that have guaranteed minimums, revenue for the guaranteed minimum is recognized on a straight-line basis during the term, until such time that the cumulative royalties exceed the total minimum guarantee. Up-front payments are recognized over the contractual term to which the guaranteed minimum relates. The Company also licenses its Famous Footwear trade name and logo to a third-party financial institution to offer Famous Footwear-branded credit cards to its consumers. The Company receives royalties based upon cardholder spending, which is recognized as licensing revenue at the time when the credit card is used. Contract Balances Revenue is recorded at the transaction price, net of estimates for variable consideration for which reserves are established, including returns, allowances and discounts. Variable consideration is estimated using the expected value method and given the large number of contracts with similar characteristics, the portfolio approach is applied to determine the variable consideration for each revenue stream. Reserves for projected returns are based on historical patterns and current expectations. Information about significant contract balances from contracts with customers is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ($ thousands) October 30, 2021 October 31, 2020 January 30, 2021 Customer allowances and discounts ​ $ 20,277 ​ $ 22,182 ​ $ 17,043 Loyalty programs liability ​ 18,354 ​ 14,634 ​ 13,986 Returns reserve ​ 15,704 ​ 14,889 ​ 11,040 Gift card liability ​ 5,034 ​ 4,909 ​ 6,091 ​ Changes in contract balances with customers generally reflect differences in relative sales volume for the periods presented. In addition, during the thirty-nine weeks ended October 30, 2021, the loyalty programs liability increased $27.4 million due to points and material rights earned on purchases and decreased $23.0 million due to expirations and redemptions. During the thirty-nine weeks ended October 31, 2020, the loyalty programs liability increased $20.7 million due to points and material rights earned on purchases and decreased $22.5 million due to expirations and redemptions. ​ The following table summarizes the activity in the Company’s allowance for expected credit losses during the thirty-nine weeks ended October 30, 2021 and October 31, 2020: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirty-Nine Weeks Ended ($ thousands) October 30, 2021 ​ October 31, 2020 Balance, beginning of period ​ $ 14,928 ​ $ 1,813 Adjustment upon adoption of ASU 2016-13 ​ ​ — ​ ​ 2,521 Provision/adjustment for expected credit losses (1) ​ ​ (2,711) ​ ​ 10,663 Uncollectible accounts written off, net of recoveries ​ ​ (2,724) ​ ​ 221 Balance, end of period ​ $ 9,493 ​ $ 15,218 (1) The Company’s provision/adjustment for expected credit losses for the thirty-nine weeks ended October 31, 2020 was higher than the comparable period in 2021 as a result of the COVID-19 pandemic and its impact on the financial condition of several of the Company’s wholesale customers.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	9 Months Ended
	Oct. 30, 2021
Earnings (Loss) Per Share
Earnings (Loss) Per Share	Note 4 Earnings (Loss) Per Share The Company uses the two-class method to compute basic and diluted earnings (loss) per common share attributable to Caleres, Inc. shareholders. In periods of net loss, no effect is given to the Company’s participating securities since they do not contractually participate in the losses of the Company. The following table sets forth the computation of basic and diluted earnings (loss) per common share attributable to Caleres, Inc. shareholders for the periods ended October 30, 2021 and October 31, 2020: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirteen Weeks Ended ​ Thirty-Nine Weeks Ended ($ thousands, except per share amounts) October 30, 2021 October 31, 2020 October 30, 2021 October 31, 2020 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ NUMERATOR ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net earnings (loss) ​ $ 59,685 ​ $ 14,926 ​ $ 104,222 ​ $ (361,915) Net earnings attributable to noncontrolling interests ​ (63) ​ (509) ​ (1,057) ​ (223) Net earnings (loss) attributable to Caleres, Inc. ​ $ 59,622 ​ $ 14,417 ​ $ 103,165 ​ $ (362,138) Net earnings allocated to participating securities ​ (2,140) ​ (512) ​ (3,737) ​ — Net earnings (loss) attributable to Caleres, Inc. after allocation of earnings to participating securities ​ $ 57,482 ​ $ 13,905 ​ $ 99,428 ​ $ (362,138) ​ ​ ​ ​ ​ DENOMINATOR ​ ​ ​ ​ Denominator for basic earnings (loss) per common share attributable to Caleres, Inc. shareholders ​ 36,889 ​ 36,554 ​ 36,825 ​ 37,439 Dilutive effect of share-based awards ​ 457 ​ 176 ​ 294 ​ — Denominator for diluted earnings (loss) per common share attributable to Caleres, Inc. shareholders ​ 37,346 ​ 36,730 ​ 37,119 ​ 37,439 ​ ​ ​ ​ ​ Basic earnings (loss) per common share attributable to Caleres, Inc. shareholders ​ $ 1.56 ​ $ 0.38 ​ $ 2.70 ​ $ (9.67) ​ ​ ​ ​ ​ Diluted earnings (loss) per common share attributable to Caleres, Inc. shareholders ​ $ 1.54 ​ $ 0.38 ​ $ 2.68 ​ $ (9.67) ​ Options to purchase 16,667 shares of common stock for both the thirteen and thirty-nine weeks ended October 30, 2021 were not included in the denominator for diluted earnings (loss) per common share attributable to Caleres, Inc. shareholders because the effect would be anti-dilutive. Options to purchase 24,667 shares of common stock were excluded from the denominator for both the thirteen and thirty-nine weeks ended October 31, 2020. During the thirty-nine weeks ended October 31, 2020, the Company repurchased 2,902,122 shares under the 2018 and 2019 publicly announced share repurchase programs, which permits repurchases of up to 2.5 million and 5.0 million shares, respectively. The Company did not repurchase any shares under the share repurchase programs during the thirteen weeks ended October 31, 2020 or the thirty-nine weeks ended October 30, 2021. Refer to further discussion in Item 2, Unregistered Sales of Equity Securities and Use of Proceeds

Restructuring and Other Special

Restructuring and Other Special Charges	9 Months Ended
	Oct. 30, 2021
Restructuring and Other Special Charges
Restructuring and Other Special Charges	Note 5 Restructuring and Other Special Charges Blowfish Mandatory Purchase Obligation In 2018, the Company acquired a controlling interest in Blowfish Malibu. The remaining interest was subject to a mandatory purchase obligation after a three-year period, which ended on July 31, 2021, based upon an earnings multiple formula as specified in the purchase agreement. Approximately $9.0 million was initially assigned to the mandatory purchase obligation and remeasurement adjustments were recorded as interest expense. The fair value adjustments on the mandatory purchase obligation totaled $1.9 million ($1.4 million on an after-tax basis, or $0.04 per diluted share) for the thirteen weeks ended October 30, 2021, reflecting the settlement of the remaining interest in Blowfish Malibu. Fair value adjustments totaled $15.4 million ($11.5 million on an after-tax basis, or $0.30 per diluted share) for the thirty-nine weeks ended October 30, 2021. For the thirteen and thirty-nine weeks ended October 31, 2020, the Company recorded fair value adjustments of $5.1 million ($3.8 million on an after-tax basis, or $0.10 per diluted share) and $14.9 million ($11.1 million on an after-tax basis, or $0.30 per diluted share), respectively. As of October 30, 2021, the mandatory purchase obligation was valued at $54.6 million. The mandatory purchase obligation was paid subsequent to the third quarter of 2021, on November 4, 2021. Refer to further discussion regarding the mandatory purchase obligation in Note 14 to the condensed consolidated financial statements. Brand Exits During the thirty-nine weeks ended October 30, 2021, the Company incurred costs of $13.5 million ($11.9 million on an after-tax basis, or $0.31 per diluted share) related to the strategic realignment of the Naturalizer retail store operations. These costs primarily represented lease termination and other store closure costs, including employee severance, for the 73 stores that were closed during the first quarter of 2021. These charges are presented in restructuring and special charges on the condensed consolidated statements of earnings (loss) within the Brand Portfolio segment for the thirty-nine weeks ended October 30, 2021. As of October 30, 2021, reserves of $2.5 million were included on the condensed consolidated balance sheets. During the thirty-nine weeks ended October 31, 2020, the Company incurred costs of $1.6 million ($1.2 million on an after-tax basis, or $0.03 per diluted share) related to the decision to exit the Fergie brand. These charges, which represented inventory markdowns required to reduce the value of inventory to net realizable value, are presented in cost of goods sold on the condensed consolidated statements of earnings (loss) within the Brand Portfolio segment for the thirty-nine weeks ended October 31, 2020. COVID-19-Related Expenses During the thirty-nine weeks ended October 31, 2020, the Company incurred costs associated with the COVID-19 pandemic and related impacts on the Company’s business totaling $99.0 million ($78.0 million on an after-tax basis, or $2.08 per diluted share). These costs included non-cash impairment of property and equipment and lease right-of-use assets, incremental inventory markdowns, employee severance and other direct expenses specific to the impact of COVID-19 on the Company’s operations. Of the $99.0 million in charges, $65.6 million is presented as restructuring and other special charges, net and $33.4 million is reflected as cost of goods sold in the condensed consolidated statements of earnings (loss). Of the $65.6 million reflected as restructuring and other special charges, $48.4 million is reflected in the Brand Portfolio segment, $16.6 million is reflected in the Famous Footwear segment and $0.6 million is reflected within the Eliminations and Other category. The $33.4 million reflected as cost of goods sold represents incremental inventory markdowns, of which $27.4 million is reflected in the Brand Portfolio segment and $6.0 million is reflected in the Famous Footwear segment. There were no corresponding special charges for the thirty-nine weeks ended October 30, 2021. Refer to Note 9 to the condensed consolidated financial statements for additional information regarding the impact of COVID-19 on the Company’s leases.

Business Segment Information

Business Segment Information	9 Months Ended
	Oct. 30, 2021
Business Segment Information
Business Segment Information	Note 6 Business Segment Information Following is a summary of certain key financial measures for the Company’s business segments for the periods ended October 30, 2021 and October 31, 2020: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Famous ​ Brand ​ Eliminations ​ ​ ​ ($ thousands) Footwear Portfolio and Other Total Thirteen Weeks Ended October 30, 2021 ​ ​ ​ ​ ​ ​ ​ ​ Net sales ​ $ 494,660 ​ $ 300,513 ​ $ (11,017) ​ $ 784,156 Intersegment sales (1) ​ — ​ ​ 11,017 ​ ​ — ​ 11,017 Operating earnings (loss) ​ 87,375 ​ 11,383 ​ (17,440) ​ 81,318 Segment assets ​ 736,858 ​ 909,175 ​ 228,525 ​ 1,874,558 ​ ​ ​ ​ ​ Thirteen Weeks Ended October 31, 2020 ​ ​ ​ ​ Net sales ​ $ 391,706 ​ $ 267,587 ​ $ (11,813) ​ $ 647,480 Intersegment sales (1) ​ — ​ 11,813 ​ — ​ 11,813 Operating earnings (loss) ​ 27,845 ​ 7,304 ​ (15,078) ​ 20,071 Segment assets ​ 837,228 ​ 924,976 ​ 264,856 ​ 2,027,060 ​ ​ ​ ​ ​ Thirty-Nine Weeks Ended October 30, 2021 ​ ​ ​ ​ ​ ​ ​ ​ Net sales ​ $ 1,346,413 ​ $ 789,832 ​ $ (37,922) ​ $ 2,098,323 Intersegment sales (1) ​ — ​ 37,922 ​ — ​ 37,922 Operating earnings (loss) ​ 220,746 ​ 25,116 ​ (83,883) ​ 161,979 ​ ​ ​ ​ ​ Thirty-Nine Weeks Ended October 31, 2020 ​ ​ ​ ​ Net sales ​ $ 916,893 ​ $ 668,447 ​ $ (39,229) ​ $ 1,546,111 Intersegment sales (1) ​ — ​ 39,229 ​ — ​ 39,229 Operating loss ​ (38,651) ​ (352,556) ​ (39,072) ​ (430,279) (1) Included in net sales in the Brand Portfolio segment and eliminated in the Eliminations and Other category. The Eliminations and Other category includes corporate assets, administrative expenses and other costs and recoveries, which are not allocated to the operating segments, as well as the elimination of intersegment sales and profit. Following is a reconciliation of operating earnings (loss) to earnings (loss) before income taxes: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirteen Weeks Ended ​ Thirty-Nine Weeks Ended ($ thousands) October 30, 2021 October 31, 2020 October 30, 2021 October 31, 2020 Operating earnings (loss) ​ $ 81,318 ​ $ 20,071 ​ $ 161,979 ​ $ (430,279) Interest expense, net ​ (5,069) ​ (10,881) ​ (28,803) ​ (33,747) Loss on early extinguishment of debt ​ (649) ​ — ​ (649) ​ — Other income, net ​ 3,844 ​ 5,461 ​ 11,533 ​ 12,718 Earnings (loss) before income taxes ​ $ 79,444 ​ $ 14,651 ​ $ 144,060 ​ $ (451,308) ​

Inventories

Inventories	9 Months Ended
	Oct. 30, 2021
Inventories
Inventories	Note 7 Inventories The Company’s net inventory balance was comprised of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ($ thousands) October 30, 2021 October 31, 2020 January 30, 2021 Raw materials ​ $ 14,951 ​ $ 14,907 ​ $ 14,592 Work-in-process ​ 581 ​ 293 ​ 349 Finished goods ​ 527,686 ​ 492,165 ​ 473,014 Inventories, net ​ $ 543,218 ​ $ 507,365 ​ $ 487,955 ​

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Oct. 30, 2021
Goodwill and Intangible Assets
Goodwill and Intangible Assets	Goodwill and intangible assets were as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ($ thousands) October 30, 2021 October 31, 2020 January 30, 2021 Intangible Assets ​ ​ ​ Famous Footwear ​ $ 2,800 ​ $ 2,800 ​ $ 2,800 Brand Portfolio ​ 342,083 ​ 365,888 ​ 342,083 Total intangible assets ​ 344,883 ​ 368,688 ​ 344,883 Accumulated amortization ​ (119,214) ​ (106,570) ​ (109,768) Total intangible assets, net ​ 225,669 ​ 262,118 ​ 235,115 Goodwill ​ ​ ​ Brand Portfolio (1) ​ 4,956 ​ 4,956 ​ 4,956 Total goodwill ​ 4,956 ​ 4,956 ​ 4,956 Goodwill and intangible assets, net ​ $ 230,625 ​ $ 267,074 ​ $ 240,071 (1) The carrying amount of goodwill as of October 30, 2021, October 31, 2020 and January 30, 2021 is presented net of accumulated impairment charges of $415.7 million. The Company’s intangible assets as of October 30, 2021, October 31, 2020 and January 30, 2021 were as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ($ thousands) October 30, 2021 ​ Estimated Useful Lives ​ ​ Accumulated Accumulated ​ ​ ​ ​ (In Years) ​ Cost Basis (2) ​ Amortization ​ Impairment ​ Net Carrying Value Trade names 2 - 40 ​ $ 299,488 ​ $ 109,545 ​ $ 10,200 ​ $ 179,743 Trade names Indefinite ​ 107,400 ​ — ​ 92,000 ​ 15,400 Customer relationships 15 - 16 44,200 9,669 4,005 30,526 ​ ​ ​ ​ $ 451,088 ​ $ 119,214 ​ $ 106,205 ​ $ 225,669 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ October 31, 2020 ​ Estimated Useful Lives ​ ​ Accumulated Accumulated ​ ​ ​ ​ (In Years) ​ Cost Basis (2) ​ Amortization ​ Impairment ​ Net Carrying Value Trade names 2 - 40 ​ $ 299,488 ​ $ 99,376 ​ $ 10,200 ​ $ 189,912 Trade names Indefinite ​ 107,400 ​ — ​ 72,200 ​ 35,200 Customer relationships 15 - 16 44,200 7,194 — 37,006 ​ ​ ​ ​ $ 451,088 ​ $ 106,570 ​ $ 82,400 ​ $ 262,118 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ January 30, 2021 ​ Estimated Useful Lives ​ ​ Accumulated Accumulated ​ ​ ​ ​ (In Years) ​ Cost Basis (2) ​ Amortization ​ Impairment ​ Net Carrying Value Trade names 2 - 40 ​ $ 299,488 ​ $ 101,919 ​ $ 10,200 ​ $ 187,369 Trade names Indefinite ​ 107,400 ​ — ​ 92,000 ​ 15,400 Customer relationships 15 - 16 44,200 7,849 4,005 32,346 ​ ​ ​ ​ $ 451,088 ​ $ 109,768 ​ $ 106,205 ​ $ 235,115 (2) The Via Spiga trade name was reclassified from indefinite-lived trade names to definite-lived trade names. The remaining carrying value of $0.1 million as of October 30, 2021 will be fully amortized by the end of fiscal 2021. Amortization expense related to intangible assets was $3.1 million and $3.3 million for the thirteen weeks ended October 30, 2021 and October 31, 2020, respectively, and $9.4 million and $9.8 million for the thirty-nine weeks ended October 30, 2021 and October 31, 2020, respectively. The Company estimates that amortization expense related to intangible assets will be approximately $12.6 million in 2021, $12.1 million in 2022, $11.9 million in 2023, and $11.0 million in 2024 and 2025. Goodwill is tested for impairment at least annually, or more frequently if events or circumstances indicate it might be impaired, using either the qualitative assessment or a quantitative fair value-based test. During the first quarter of 2020, as a result of the significant decline in the Company’s share price and market capitalization and the impact of the pandemic on the Company’s business operations, the Company determined that an interim assessment of goodwill was required. A quantitative assessment was performed for all reporting units as of May 2, 2020. The assessment indicated that the carrying value of the goodwill associated with the Brand Portfolio and Vionic reporting units was impaired, resulting in total goodwill impairment charges of $240.3 million. The Company recorded no goodwill impairment charges during the thirty-nine weeks ended October 30, 2021 or the thirteen weeks ended October 31, 2020. Indefinite-lived intangible assets are tested for impairment as of the first day of the fourth quarter of each fiscal year unless events or circumstances indicate an interim test is required. As a result of the triggering event from the economic impacts of COVID-19, an interim assessment was performed as of May 2, 2020. The indefinite-lived intangible asset impairment review resulted in total impairment charges of $22.4 million during the first quarter of 2020, including $12.2 million associated with the indefinite-lived Allen Edmonds trade name and $10.2 million of impairment associated with the indefinite-lived Via Spiga trade name. The carrying value of the Via Spiga trade name of $0.5 million is being amortized over approximately two years. In addition to the interim assessment, the Company tested the indefinite-lived intangible assets as of the first day of the fourth fiscal quarter. As a result of the impairment indicator for Allen Edmonds, the Company also tested the definite-lived Allen Edmonds customer relationships intangible asset. Those assessments resulted in additional impairment totaling $23.8 million, consisting of $19.8 million associated with the Allen Edmonds trade name and $4.0 million associated with the Allen Edmonds customer relationships intangible asset. The Company recorded no impairment charges during the thirty-nine weeks ended October 30, 2021 or the thirteen weeks ended October 31, 2020.

Leases

Leases	9 Months Ended
	Oct. 30, 2021
Leases
Leases	Note 9 Leases The Company leases all of its retail locations, a manufacturing facility, and certain office locations, distribution centers and equipment. At contract inception, leases are evaluated and classified as either operating or finance leases. Leases with an initial term of 12 months or less are not recorded on the balance sheet. Lease right-of-use assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term. The majority of the Company’s leases do not provide an implicit rate and therefore, the Company uses an incremental borrowing rate based on information available at the commencement date to determine the present value of future payments. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred. The Company regularly analyzes the results of all of its stores and assesses the viability of underperforming stores to determine whether events or circumstances exist that indicate the stores should be closed or whether the carrying amount of their long-lived assets may not be recoverable. After allowing for an appropriate start-up period and consideration of any unusual nonrecurring events, property and equipment at stores and the lease right-of-use assets indicated as impaired are written down to fair value as calculated using a discounted cash flow method. The fair value of the lease right-of-use assets is determined utilizing projected cash flows for each store location, discounted using a risk-adjusted discount rate, subject to a market floor based on current market lease rates. The Company recorded asset impairment charges of $1.1 million and $0.4 million during the thirteen weeks ended October 30, 2021 and October 31, 2020, respectively. The Company recorded asset impairment charges of $3.4 million and $35.6 million during the thirty-nine weeks ended October 30, 2021 and October 31, 2020, respectively. The impairment charges recorded in the thirteen and thirty-nine weeks ended October 30, 2021 are related to underperforming retail stores. The impairment charges recorded in the thirty-nine weeks ended October 31, 2020, including $21.1 million associated with operating lease right-of-use assets and $14.5 million associated with property and equipment, reflect the impact of the COVID-19 pandemic on the Company’s retail operations and estimates of remaining cash flows for each store. Refer to Note 5 and Note 14 to the condensed consolidated financial statements for further discussion on these impairment charges. As a result of the temporary store closures during the first half of 2020 associated with the pandemic, certain leases were amended to provide rent abatements and/or deferral of lease payments. Deferred payments continue to be reflected in lease obligations on the condensed consolidated balance sheets. Under relief provided by the FASB, entities could make a policy election to account for COVID-19-related lease concessions as if the enforceable rights existed under the original contract, accounting for them as variable rent rather than lease modifications. The Company made a policy election to account for rent abatements as variable rent. Accordingly, during the thirteen and thirty-nine weeks ended October 30, 2021, the Company recorded $0.1 million and $1.7 million, respectively, in lease concessions as a reduction of rent expense within selling and administrative expenses in the condensed consolidated statements of earnings (loss). During the thirteen and thirty-nine weeks ended October 31, 2020, the Company recorded $1.7 million and $3.7 million in lease concessions. Rent concessions for leases that were extended were recognized as a lease modification. During the thirty-nine weeks ended October 30, 2021, the Company entered into new or amended leases that resulted in the recognition of right-of-use assets and lease obligations of $77.7 million on the condensed consolidated balance sheets. As of October 30, 2021, the Company has entered into lease commitments for two retail locations for which the leases have not yet commenced. The Company anticipates that both leases will begin in the next fiscal year. Upon commencement, right-of-use assets and lease liabilities of approximately $1.3 million will be recorded in the next The components of lease expense for the thirteen and thirty-nine weeks ended October 30, 2021 and October 31, 2020 were as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirteen Weeks Ended ($ thousands) ​ October 30, 2021 October 31, 2020 Operating lease expense $ 35,140 $ 38,568 Variable lease expense ​ 10,982 ​ 12,739 Short-term lease expense ​ 737 ​ 1,775 Sublease income ​ (419) ​ (29) Total lease expense ​ $ 46,440 ​ $ 53,053 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirty-Nine Weeks Ended ($ thousands) ​ October 30, 2021 October 31, 2020 Operating lease expense $ 112,838 $ 124,906 Variable lease expense ​ 30,985 ​ 36,090 Short-term lease expense ​ 2,011 ​ 3,872 Sublease income ​ (477) ​ (76) Total lease expense ​ $ 145,357 ​ $ 164,792 ​ Supplemental cash flow information related to leases is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirty-Nine Weeks Ended ($ thousands) October 30, 2021 October 31, 2020 Cash paid for lease liabilities (1) ​ $ 140,930 ​ $ 99,517 Cash received from sublease income ​ 477 ​ 76 ​ (1) Cash paid for lease liabilities for the thirty-nine weeks ended October 30, 2021 includes payment of certain lease payments deferred in 2020, as described above, as well as lease termination costs associated with the Naturalizer retail store closings, as further discussed in Note 5 to the condensed consolidated financial statements. In addition, cash paid for lease liabilities during the thirty-nine weeks ended October 31, 2020 was significantly lower than comparable periods, reflecting the deferral of lease payments during the onset of the pandemic.

Long-term and Short-term Financ

Long-term and Short-term Financing Arrangements	9 Months Ended
	Oct. 30, 2021
Long-term and Short-term Financing Arrangements
Long-term and Short-term Financing Arrangements	Note 10 Long-term and Short-term Financing Arrangements Credit Agreement The Company maintains a revolving credit facility for working capital needs. The Company is the lead borrower, and Sidney Rich Associates, Inc., BG Retail, LLC, Allen Edmonds LLC, Vionic Group LLC and Vionic International LLC are each co-borrowers and guarantors. On October 5, 2021, the Company entered into a Fifth Amendment to Fourth Amended and Restated Credit Agreement (as so amended, the "Credit Agreement") which, among other modifications, decreased the amount available under the revolving credit facility by $100.0 million to an aggregate amount of up to $500.0 million, subject to borrowing base restrictions, and may be further increased by up to $250.0 million. The Credit Agreement also decreased the spread applied to the London Interbank Offered Rate (“LIBOR”) or prime rate by a total of 75 basis points. Borrowing availability under the Credit Agreement is limited to the lesser of the total commitments and the borrowing base ("Loan Cap"), which is based on stated percentages of the sum of eligible accounts receivable, eligible inventory and eligible credit card receivables, as defined, less applicable reserves. Under the Credit Agreement, the Loan Parties’ obligations are secured by a first-priority security interest in all accounts receivable, inventory and certain other collateral. Interest on borrowings is at variable rates based on LIBOR (with a floor of 0.0%), or the prime rate (as defined in the Credit Agreement), plus a spread. The interest rate and fees for letters of credit vary based upon the level of excess availability under the Credit Agreement. There is an unused line fee payable on the unused portion under the facility and a letter of credit fee payable on the outstanding face amount under letters of credit. The Credit Agreement limits the Company’s ability to create, incur, assume or permit to exist additional indebtedness and liens, make investments or specified payments, give guarantees, pay dividends, make capital expenditures and merge or acquire or sell assets. In addition, if excess availability falls below the greater of 10.0% of the Loan Cap and $40.0 million for three consecutive business days, and the fixed charge coverage ratio is less than 1.25 to 1.0, the Company would be in default under the Credit Agreement and certain additional covenants would be triggered. The Credit Agreement contains customary events of default, including, without limitation, payment defaults, breaches of representations and warranties, covenant defaults, cross-defaults to similar obligations, certain events of bankruptcy and insolvency, judgment defaults and the failure of any guaranty or security document supporting the agreement to be in full force and effect. If an event of default occurs, the collateral agent may assume dominion and control over the Company’s cash (a “cash dominion event”) until such event of default is cured or waived or the excess availability exceeds such amount for 30 consecutive days, provided that a cash dominion event shall be deemed continuing (even if an event of default is no longer continuing and/or excess availability exceeds the required amount for 30 consecutive business days) after a cash dominion event has occurred and been discontinued on two occasions in any 12-month period. The Credit Agreement also contains certain other covenants and restrictions. The Company was in compliance with all covenants and restrictions under the Credit Agreement as of October 30, 2021. At October 30, 2021, the Company had $175.0 million of borrowings outstanding and $12.5 million in letters of credit outstanding under the Credit Agreement. Total additional borrowing availability was $312.5 million at October 30, 2021. Senior Notes On July 27, 2015, the Company issued $200.0 million aggregate principal amount of Senior Notes due on August 15, 2023 (the "Senior Notes"). The Senior Notes bear interest at 6.25%, which is payable on February 15 and August 15 of each year. The Senior Notes are guaranteed on a senior unsecured basis by each of the Company’s subsidiaries that is a borrower or guarantor under the Credit Agreement. ​ If the Company experiences specific kinds of changes of control, it would be required to offer to purchase the Senior Notes at a purchase price equal to 101% of the principal amount, plus accrued and unpaid interest and Additional Interest, if any, to, but not including, the date of repurchase. The Senior Notes also contain covenants and restrictions that limit certain activities including, among other things, levels of indebtedness, payments of dividends, the guarantee or pledge of assets, certain investments, common stock repurchases, mergers and acquisitions and sales of assets. As of October 30, 2021, the Company was in compliance with all covenants and restrictions relating to the Senior Notes. ​ On August 16, 2021, the Company redeemed $100.0 million of Senior Notes at 100.0%. During the thirteen weeks ended October 30, 2021, the Company determined that it would redeem the remaining $100.0 million of Senior Notes during the fourth quarter of 2021. Accordingly, the Company classified $100.0 million aggregate principal amount of its Senior Notes as a current liability. On November 18, 2021, the Company notified the holders of the Senior Notes that the remaining $100.0 million would be redeemed in January 2022.

Shareholders' Equity

Shareholders' Equity	9 Months Ended
	Oct. 30, 2021
Shareholders' Equity
Shareholders' Equity	Note 11 Shareholders’ Equity Accumulated Other Comprehensive Loss The following table sets forth the changes in accumulated other comprehensive loss (OCL) by component for the periods ended October 30, 2021 and October 31, 2020: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Pension and Derivative ​ ​ ​ ​ ​ ​ ​ Other ​ Financial ​ Accumulated ​ ​ Foreign ​ Postretirement ​ Instrument ​ Other ​ ​ Currency ​ Transactions ​ Transactions ​ Comprehensive ($ thousands) ​ Translation ​ (1) ​ (2) ​ (Loss) Income Balance at July 31, 2021 ​ $ (260) ​ $ (8,312) ​ $ — ​ $ (8,572) Other comprehensive loss before reclassifications ​ ​ (257) ​ ​ — ​ ​ — ​ ​ (257) Reclassifications: ​ ​ ​ ​ ​ ​ ​ ​ Amounts reclassified from accumulated other comprehensive loss ​ ​ — ​ ​ 445 ​ ​ — ​ ​ 445 Tax benefit ​ — ​ (87) ​ — ​ (87) Net reclassifications ​ — ​ 358 ​ — ​ 358 Other comprehensive (loss) income ​ (257) ​ 358 ​ — ​ 101 Balance at October 30, 2021 ​ $ (517) ​ $ (7,954) ​ $ — ​ $ (8,471) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Balance at August 1, 2020 ​ $ (1,390) ​ $ (30,047) ​ $ — ​ $ (31,437) Other comprehensive income before reclassifications ​ 320 ​ — ​ — ​ 320 Reclassifications: ​ ​ ​ ​ Amounts reclassified from accumulated other comprehensive loss ​ — ​ (111) ​ — ​ (111) Tax provision (3) ​ — ​ 44 ​ — ​ 44 Net reclassifications ​ — ​ (67) ​ — ​ (67) Other comprehensive income (loss) ​ 320 ​ (67) ​ — ​ 253 Balance at October 31, 2020 ​ $ (1,070) ​ $ (30,114) ​ $ — ​ $ (31,184) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Balance at January 30, 2021 ​ $ (111) ​ $ (9,025) ​ $ — ​ $ (9,136) Other comprehensive loss before reclassifications ​ (406) ​ — ​ — ​ (406) Reclassifications: ​ ​ ​ ​ ​ Amounts reclassified from accumulated other comprehensive loss ​ — ​ 1,340 ​ — ​ 1,340 Tax benefit ​ — ​ (269) ​ — ​ (269) Net reclassifications ​ — ​ 1,071 ​ — ​ 1,071 Other comprehensive (loss) income ​ (406) ​ 1,071 ​ — ​ 665 Balance at October 30, 2021 ​ $ (517) ​ $ (7,954) ​ $ — ​ $ (8,471) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Balance at February 1, 2020 ​ $ (580) ​ $ (31,171) ​ $ (92) ​ $ (31,843) Other comprehensive (loss) income before reclassifications ​ (490) ​ — ​ 87 ​ (403) Reclassifications: ​ ​ ​ ​ Amounts reclassified from accumulated other comprehensive loss ​ — ​ 1,393 ​ 6 ​ 1,399 Tax benefit (3) ​ — ​ (336) ​ (1) ​ (337) Net reclassifications ​ — ​ 1,057 ​ 5 ​ 1,062 Other comprehensive (loss) income ​ (490) ​ 1,057 ​ 92 ​ 659 Balance at October 31, 2020 ​ $ (1,070) ​ $ (30,114) ​ $ — ​ $ (31,184) (1) Amounts reclassified are included in other income, net. Refer to Note 13 to the condensed consolidated financial statements for additional information related to pension and other postretirement benefits. (2) Amounts reclassified are included in net sales, costs of goods sold and selling and administrative expenses. Refer to Note 1 to the condensed consolidated financial statements for additional information related to derivative financial instruments . (3) Includes approximately $0.5 million of expense related to a valuation allowance on net deferred taxes, including those related to other comprehensive income, for the Company’s Canadian subsidiary.

Share-Based Compensation

Share-Based Compensation	9 Months Ended
	Oct. 30, 2021
Share-Based Compensation
Share-Based Compensation	Note 12 Share-Based Compensation The Company recognized share-based compensation expense of $3.4 million and $2.5 million during the thirteen weeks and $8.8 million and $6.9 million during the thirty-nine weeks ended October 30, 2021 and October 31, 2020, respectively. The Company had net (repurchases) issuances of (10,554) and 32,018 shares of common stock during the thirteen weeks ended October 30, 2021 and October 31, 2020, respectively, for restricted stock grants, stock performance awards issued to employees and common and restricted stock grants issued to non-employee directors, net of forfeitures and shares withheld to satisfy the tax withholding requirement. During the thirty-nine weeks ended October 30, 2021 and October 31, 2020, the Company had net issuances of 291,306 and 449,539 shares of common stock, respectively, related to the share-based plans. Restricted Stock The following table summarizes restricted stock activity for the periods ended October 30, 2021 and October 31, 2020: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirteen Weeks Ended ​ ​ ​ Thirteen Weeks Ended ​ ​ October 30, 2021 ​ ​ ​ October 31, 2020 ​ ​ ​ ​ ​ Weighted- ​ ​ ​ ​ ​ ​ Weighted- ​ ​ Total Number ​ ​ Average ​ ​ ​ Total Number ​ ​ Average ​ ​ of Restricted ​ ​ Grant Date ​ ​ ​ of Restricted ​ ​ Grant Date ​ Shares ​ Fair Value ​ Shares ​ Fair Value July 31, 2021 ​ 1,380,246 ​ $ 14.05 ​ August 1, 2020 ​ 1,360,602 ​ $ 17.81 Granted ​ — ​ ​ — ​ Granted ​ 35,000 ​ ​ 9.73 Forfeited ​ (9,500) ​ ​ 15.72 ​ Forfeited ​ (875) ​ ​ 14.51 Vested (3,500) ​ 26.42 Vested (6,500) ​ 25.18 October 30, 2021 1,367,246 ​ $ 14.01 ​ October 31, 2020 1,388,227 ​ $ 17.57 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirty-Nine Weeks Ended ​ ​ ​ Thirty-Nine Weeks Ended ​ October 30, 2021 ​ October 31, 2020 ​ ​ ​ ​ Weighted- ​ ​ ​ ​ ​ Weighted- ​ ​ Total Number ​ Average ​ ​ ​ Total Number ​ Average ​ ​ of Restricted ​ Grant Date ​ ​ ​ of Restricted ​ Grant Date ​ ​ Shares ​ Fair Value ​ ​ ​ Shares ​ Fair Value January 30, 2021 1,397,227 ​ $ 16.74 ​ February 1, 2020 1,271,795 ​ $ 26.77 Granted 568,916 ​ 18.73 ​ Granted 598,431 ​ 6.14 Forfeited (78,375) ​ 15.48 ​ Forfeited (68,787) ​ 23.11 Vested (520,522) ​ 26.26 ​ Vested (413,212) ​ 28.23 October 30, 2021 1,367,246 ​ $ 14.01 ​ October 31, 2020 1,388,227 ​ $ 17.57 ​ There were no restricted shares granted during the thirteen weeks ended October 30, 2021. Of the 568,916 restricted shares granted during the thirty-nine weeks ended October 30, 2021, 4,910 shares have a cliff-vesting term of one year, 20,000 shares have a cliff-vesting term of two years and 544,006 shares have a graded-vesting term of three years, with 50% vesting after two years and 50% after three years. All of the restricted shares granted during the thirteen weeks ended October 31, 2020 have a graded-vesting term of three years, with 50% vesting after two years and 50% after three years. Of the 598,431 restricted shares granted during the thirty-nine weeks ended October 31, 2020, 585,683 shares have a graded-vesting term of three years, with 50% vesting after two years and 50% after three years and 12,748 shares have a cliff-vesting term of one year. Share-based compensation expense for graded-vesting grants is recognized ratably over the respective vesting periods. Performance Share Awards There were no performance-based share awards granted by the Company during the thirteen weeks ended October 30, 2021. During the thirty-nine weeks ended October 30, 2021, the Company granted performance share awards for a targeted 175,500 shares, with a weighted-average grant date fair value of $18.63 in connection with the 2020 performance award. During the thirteen and thirty-nine weeks ended October 31, 2020, the Company granted performance share awards for a targeted 87,750 shares, with a weighted-average grant date fair value of $7.47. Vesting of performance-based awards is generally dependent upon the financial performance of the Company and the attainment of certain financial goals during the three-year period following the grant. At the end of the vesting period, the employee will have earned an amount of shares or units between 0% and 200% of the targeted award, depending on the achievement of the specified financial goals for the service period. Compensation expense is recognized based on the fair value of the award and the anticipated number of shares or units to be awarded for each tranche in accordance with the vesting schedule of the units over the three-year service period. During the thirty-nine weeks ended October 30, 2021, the Company granted long-term incentive awards payable in cash for the 2021-2023 performance period, with a target value of $6.5 million and a maximum value of $13.0 million. These awards, which vest after a three-year period, are dependent upon the attainment of certain financial goals of the Company for each of the three years and individual achievement of strategic initiatives over the cumulative period of the award. The estimated value of the award, which is reflected within other liabilities on the condensed consolidated balance sheets, is being accrued over the three-year performance period. There were no long-term cash incentive awards granted by the Company during the thirteen weeks ended October 30, 2021 or during the thirty-nine weeks ended October 31, 2020. ​ Restricted Stock Units for Non-Employee Directors Equity-based grants may be made to non-employee directors in the form of restricted stock units ("RSUs") payable in cash or common stock at no cost to the non-employee director. The RSUs earn dividend equivalents at the same rate as dividends on the Company’s common stock. The dividend equivalents, which vest immediately, are automatically re-invested in additional RSUs. Expense related to the initial grant of RSUs is recognized ratably over the vesting period based upon the fair value of the RSUs. The RSUs payable in cash are remeasured at the end of each period. Expense for the dividend equivalents is recognized at fair value when the dividend equivalents are granted. The Company granted 1,739 and 3,618 for dividend equivalents, during the thirteen weeks ended October 30, 2021 and October 31, 2020, respectively, with weighted-average grant date fair values of $22.49 and $9.78, respectively. The Company granted 44,180 and 118,150 RSUs to non-employee directors, including 4,900 and 16,166 for dividend equivalents, during the thirty-nine weeks ended October 30, 2021 and October 31, 2020, respectively, with weighted-average grant date fair values of $27.03 and $10.01, respectively.

Retirement and Other Benefit Pl

Retirement and Other Benefit Plans	9 Months Ended
	Oct. 30, 2021
Retirement and Other Benefit Plans
Retirement and Other Benefit Plans	Note 13 Retirement and Other Benefit Plans The following table sets forth the components of net periodic benefit income for the Company, including domestic and Canadian plans: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Pension Benefits ​ Other Postretirement Benefits ​ Thirteen Weeks Ended Thirteen Weeks Ended ($ thousands) ​ October 30, 2021 October 31, 2020 October 30, 2021 October 31, 2020 Service cost ​ $ 1,872 ​ $ 2,005 ​ $ — ​ $ — Interest cost ​ 2,811 ​ 2,970 ​ 8 ​ 10 Expected return on assets ​ (7,108) ​ (8,330) ​ — ​ — Amortization of: ​ ​ ​ ​ ​ ​ Actuarial loss (gain) ​ 601 ​ 240 ​ (27) ​ (27) Prior service income ​ (129) ​ (324) ​ — ​ — Total net periodic benefit income ​ $ (1,953) ​ $ (3,439) ​ $ (19) ​ $ (17) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Pension Benefits ​ Other Postretirement Benefits ​ Thirty-Nine Weeks Ended Thirty-Nine Weeks Ended ($ thousands) October 30, 2021 October 31, 2020 October 30, 2021 October 31, 2020 Service cost ​ $ 5,615 ​ $ 6,412 ​ $ — ​ $ — Interest cost ​ 8,430 ​ 9,252 ​ 28 ​ 31 Expected return on assets ​ (21,331) ​ (23,205) ​ — ​ — Amortization of: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Actuarial loss (gain) ​ 1,808 ​ 2,506 ​ (82) ​ (82) Prior service income ​ (386) ​ (1,031) ​ — ​ — Settlement cost ​ — ​ 222 ​ — ​ — Curtailment gain ​ — ​ (189) ​ — ​ — Total net periodic benefit income ​ $ (5,864) ​ $ (6,033) ​ $ (54) ​ $ (51) ​ The non-service cost components of net periodic benefit income are included in other income, net in the condensed consolidated statements of earnings (loss). Service cost is included in selling and administrative expenses.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 30, 2021
Fair Value Measurements
Fair Value Measurements	Note 14 Fair Value Measurements Fair Value Hierarchy Fair value measurement disclosure requirements specify a hierarchy of valuation techniques based upon whether the inputs to those valuation techniques reflect assumptions other market participants would use based upon market data obtained from independent sources (“observable inputs”) or reflect the Company’s own assumptions of market participant valuation (“unobservable inputs”). In accordance with the fair value guidance, the inputs to valuation techniques used to measure fair value are categorized into three levels based on the reliability of the inputs as follows: ● Level 1 – Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities; ● Level 2 – Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and ● Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. ​ In determining fair value, the Company uses valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company also considers counterparty credit risk in its assessment of fair value. Classification of the financial or non-financial asset or liability within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. Measurement of Fair Value The Company measures fair value as an exit price, the price to sell an asset or transfer a liability in an orderly transaction between market participants at the measurement date, using the procedures described below for all financial and non-financial assets and liabilities measured at fair value. Money Market Funds The Company has cash equivalents consisting of short-term money market funds backed by U.S. Treasury securities. The primary objective of these investing activities is to preserve the Company’s capital for the purpose of funding operations, and it does not enter into money market funds for trading or speculative purposes. The fair value is based on unadjusted quoted market prices for the funds in active markets with sufficient volume and frequency (Level 1). Non-Qualified Deferred Compensation Plan Assets and Liabilities The Company maintains a non-qualified deferred compensation plan (the “Deferred Compensation Plan”) for the benefit of certain management employees. The investment funds offered to the participants generally correspond to the funds offered in the Company’s 401(k) plan, and the account balance fluctuates with the investment returns on those funds. The Deferred Compensation Plan permits the deferral of up to 50% of base salary and 100% of compensation received under the Company’s annual incentive plan. The deferrals are held in a separate trust, which has been established by the Company to administer the Deferred Compensation Plan. The assets of the trust are subject to the claims of the Company’s creditors in the event that the Company becomes insolvent. Consequently, the trust qualifies as a grantor trust for income tax purposes (i.e., a “Rabbi Trust”). The liabilities of the Deferred Compensation Plan are presented in other accrued expenses and the assets held by the trust are classified within prepaid expenses and other current assets in the accompanying condensed consolidated balance sheets. Changes in deferred compensation plan assets and liabilities are charged to selling and administrative expenses. The fair value is based on unadjusted quoted market prices for the funds in active markets with sufficient volume and frequency (Level 1). Deferred Compensation Plan for Non-Employee Directors Non-employee directors are eligible to participate in a deferred compensation plan with deferred amounts valued as if invested in the Company’s common stock through the use of phantom stock units (“PSUs”). Under the plan, each participating director’s account is credited with the number of PSUs equal to the number of shares of the Company’s common stock that the participant could purchase or receive with the amount of the deferred compensation, based upon the average of the high and low prices of the Company’s common stock on the last trading day of the fiscal quarter when the cash compensation was earned. Dividend equivalents are paid on PSUs at the same rate as dividends on the Company’s common stock and are re-invested in additional PSUs at the next fiscal quarter-end. The liabilities of the plan are based on the fair value of the outstanding PSUs and are presented in other accrued expenses (current portion) or other liabilities in the accompanying condensed consolidated balance sheets. Gains and losses resulting from changes in the fair value of the PSUs are presented in selling and administrative expenses in the Company’s condensed consolidated statements of earnings (loss). The fair value of each PSU is based on an unadjusted quoted market price for the Company’s common stock in an active market with sufficient volume and frequency on each measurement date (Level 1). Restricted Stock Units for Non-Employee Directors Under the Company’s incentive compensation plans, cash-equivalent restricted stock units (“RSUs”) of the Company were previously granted at no cost to non-employee directors. These cash-equivalent RSUs are subject to a vesting requirement (usually one year), earn dividend-equivalent units, and are settled in cash on the date the director terminates service or such earlier date as a director may elect, subject to restrictions, based on the then current fair value of the Company’s common stock. The fair value of each cash-equivalent RSU is based on an unadjusted quoted market price for the Company’s common stock in an active market with sufficient volume and frequency on each measurement date (Level 1). Additional information related to RSUs for non-employee directors is disclosed in Note 12 to the condensed consolidated financial statements. Mandatory Purchase Obligation The Company recorded a mandatory purchase obligation of the remaining interest in conjunction with the acquisition of Blowfish Malibu in July 2018. The fair value of the mandatory purchase obligation was based on the earnings formula specified in the purchase agreement (Level 3). Fair value adjustments on the mandatory purchase obligation were recorded as interest expense. During the thirteen weeks ended October 30, 2021 and October 31, 2020, the Company recorded fair value adjustments of $1.9 million and $5.1 million, respectively. During the thirty-nine weeks ended October 30, 2021 and October 31, 2020, the Company recorded fair value adjustments of $15.4 million and $14.9 million, respectively. The mandatory purchase obligation of $54.6 million was paid on November 4, 2021. Refer to further discussion of the mandatory purchase obligation in Note 5 to the condensed consolidated financial statements. The following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis at October 30, 2021, October 31, 2020 and January 30, 2021. During the thirty-nine weeks ended October 30, 2021 and October 31, 2020, there were no transfers into or out of Level 3. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fair Value Measurements ($ thousands) Total Level 1 Level 2 Level 3 Asset (Liability) ​ ​ ​ ​ ​ ​ ​ ​ October 30, 2021: ​ ​ ​ ​ ​ ​ ​ ​ Cash equivalents – money market funds ​ $ 35,000 ​ $ 35,000 ​ $ — ​ $ — Non-qualified deferred compensation plan assets ​ 7,789 ​ 7,789 ​ — ​ ​ — Non-qualified deferred compensation plan liabilities ​ (7,789) ​ (7,789) ​ — ​ ​ — Deferred compensation plan liabilities for non-employee directors ​ (1,764) ​ (1,764) ​ — ​ ​ — Restricted stock units for non-employee directors ​ (2,558) ​ (2,558) ​ — ​ ​ — Mandatory purchase obligation - Blowfish Malibu ​ (54,558) ​ — ​ — ​ ​ (54,558) October 31, 2020: ​ ​ ​ ​ ​ ​ ​ ​ Cash equivalents – money market funds ​ $ 82,500 ​ $ 82,500 ​ $ — ​ $ — Non-qualified deferred compensation plan assets ​ ​ 7,741 ​ ​ 7,741 ​ ​ — ​ ​ — Non-qualified deferred compensation plan liabilities ​ (7,741) ​ (7,741) ​ — ​ ​ — Deferred compensation plan liabilities for non-employee directors ​ (813) ​ (813) ​ — ​ ​ — Restricted stock units for non-employee directors ​ (840) ​ (840) ​ — ​ ​ — Mandatory purchase obligation - Blowfish Malibu ​ (30,146) ​ — ​ — ​ ​ (30,146) January 30, 2021: ​ ​ ​ ​ ​ ​ ​ ​ Cash equivalents – money market funds ​ $ 45,000 ​ $ 45,000 ​ $ — ​ $ — Non-qualified deferred compensation plan assets ​ 7,918 ​ 7,918 ​ — ​ ​ — Non-qualified deferred compensation plan liabilities ​ (7,918) ​ (7,918) ​ — ​ ​ — Deferred compensation plan liabilities for non-employee directors ​ (989) ​ (989) ​ — ​ ​ — Restricted stock units for non-employee directors ​ (1,661) ​ (1,661) ​ — ​ ​ — Mandatory purchase obligation - Blowfish Malibu ​ (39,134) ​ — ​ — ​ ​ (39,134) ​ Impairment Charges The Company assesses the impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company considers important that could trigger an impairment review include underperformance relative to historical or projected future operating results, a significant change in the manner of the use of the asset, or a negative industry or economic trend. When the Company determines that the carrying value of long-lived assets may not be recoverable based upon the existence of one or more of the aforementioned factors, impairment is measured based on a projected discounted cash flow method. Certain factors, such as estimated store sales and expenses, used for this nonrecurring fair value measurement are considered Level 3 inputs as defined by FASB ASC Topic 820, Fair Value Measurement $657.6 million at October 30, 2021 and October 31, 2020, respectively, were assessed for indicators of impairment and written down to their fair value. This assessment resulted in the following impairment charges, primarily for operating lease right-of-use assets, leasehold improvements and furniture and fixtures in the Company’s retail stores. Higher impairment charges were recorded in the thirty-nine weeks ended October 31, 2020, reflecting the deteriorating economic conditions driven in part by the COVID-19 pandemic, as further discussed in Note 5 and Note 9 to the condensed consolidated financial statements. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirteen Weeks Ended ​ Thirty-Nine Weeks Ended ($ thousands) October 30, 2021 October 31, 2020 October 30, 2021 October 31, 2020 Long-Lived Asset Impairment Charges ​ ​ ​ ​ Famous Footwear ​ $ 400 ​ $ — ​ $ 1,200 ​ $ 14,896 Brand Portfolio ​ 711 ​ 398 ​ 2,199 ​ 20,724 Total long-lived asset impairment charges ​ $ 1,111 ​ $ 398 ​ $ 3,399 ​ $ 35,620 ​ Fair Value of the Company’s Other Financial Instruments The fair values of cash and cash equivalents (excluding money market funds discussed above), receivables and trade accounts payable approximate their carrying values due to the short-term nature of these instruments. The carrying amounts and fair values of the Company’s other financial instruments subject to fair value disclosures are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ October 30, 2021 October 31, 2020 January 30, 2021 ​ ​ Carrying ​ ​ ​ ​ Carrying ​ ​ ​ ​ Carrying ​ ​ ​ ($ thousands) Value (1) Fair Value Value (1) Fair Value Value (1) Fair Value Borrowings under revolving credit agreement ​ $ 175,000 ​ $ 175,000 ​ $ 300,000 ​ $ 300,000 ​ $ 250,000 ​ $ 250,000 Current portion of long-term debt ​ ​ 100,000 ​ ​ 100,000 ​ ​ — ​ ​ — ​ ​ — ​ ​ — Long-term debt ​ — ​ — ​ 200,000 ​ 188,750 ​ 200,000 ​ 201,000 Total debt ​ $ 275,000 ​ $ 275,000 ​ $ 500,000 ​ $ 488,750 ​ $ 450,000 ​ $ 451,000 (1) Excludes unamortized debt issuance costs and debt discount The fair values of borrowings under the revolving credit agreement and current portion of long-term debt approximate their carrying values due to the short-term nature of these borrowings (Level 1). The fair value of the Company’s long-term debt was based upon quoted prices in an inactive market as of the end of the respective periods (Level 2).

Income Taxes

Income Taxes	9 Months Ended
	Oct. 30, 2021
Income Taxes
Income Taxes	Note 15 Income Taxes The Company’s consolidated effective tax rate can vary considerably from period to period, depending on a number of factors. The Company’s consolidated effective tax rates were a provision of 24.9% and a benefit of 1.9% for the thirteen weeks ended October 30, 2021 and October 31, 2020, respectively. The lower effective tax rate for the thirteen weeks ended October 31, 2020 reflects the impact of a higher anticipated full year tax benefit, driven by the impact of the CARES Act, which permitted the Company to carry back 2020 losses to years with a higher federal tax rate, and the mix of projected earnings between international and domestic jurisdictions. The Company’s consolidated effective tax rate was a provision of 27.7% for the thirty-nine weeks ended October 30, 2021, compared to a benefit of 19.8% for the thirty-nine weeks ended October 31, 2020. The higher tax rate for the thirty-nine weeks ended October 30, 2021 primarily reflects strong domestic earnings and incremental valuation allowances for the Company’s deferred tax assets in certain jurisdictions. The rate also reflects the non-deductibility of losses at the Company’s Canadian business division, which were driven by exit-related costs associated with Naturalizer retail stores during the first quarter of 2021. The Company's effective tax rate for the thirty-nine weeks ended October 31, 2020 was impacted by several discrete tax items, including the non-deductibility of a portion of the Company's intangible asset impairment charges, the provision of a valuation allowance related to certain state and Canada deferred tax assets, and the incremental tax provision related to the vesting of stock awards. Offsetting these impacts was a benefit associated with the CARES Act, which permitted the Company to carry back 2020 losses to years with a higher federal tax rate. As of October 30, 2021, no deferred taxes have been provided on the accumulated unremitted earnings of the Company’s foreign subsidiaries that are not subject to United States income tax, beyond the amounts recorded for the one-time transition tax for the mandatory deemed repatriation of cumulative foreign earnings, as required by the Tax Cuts and Jobs Act. The Company periodically evaluates its foreign investment opportunities and plans, as well as its foreign working capital needs, to determine the level of investment required and, accordingly, determines the level of foreign earnings that is considered indefinitely reinvested. Based upon that evaluation, earnings of the Company’s foreign subsidiaries that are not otherwise subject to United States taxation are considered to be indefinitely reinvested, and accordingly, deferred taxes have not been provided. If changes occur in future investment opportunities and plans, those changes will be reflected when known and may result in providing residual United States deferred taxes on unremitted foreign earnings.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 30, 2021
Commitments and Contingencies
Commitments and Contingencies	Note 16 Commitments and Contingencies Environmental Remediation Prior operations included numerous manufacturing and other facilities for which the Company may have responsibility under various environmental laws for the remediation of conditions that may be identified in the future. The Company is involved in environmental remediation and ongoing compliance activities at several sites and has been notified that it is or may be a potentially responsible party at several other sites. Redfield The Company is remediating, under the oversight of Colorado authorities, the groundwater and indoor air at its owned facility in Colorado (the “Redfield site” or, when referring to remediation activities at or under the facility, the “on-site remediation”) and residential neighborhoods adjacent to and near the property (the “off-site remediation”) that have been affected by solvents previously used at the facility. The on-site remediation calls for the operation of a pump and treat system (which prevents migration of contaminated groundwater off the property) as the final remedy for the site, subject to monitoring and periodic review of the on-site conditions and other remedial technologies that may be developed in the future. In 2016, the Company submitted a revised plan to address on-site conditions, including direct treatment of source areas, and received approval from the oversight authorities to begin implementing the revised plan. As the treatment of the on-site source areas progresses, the Company expects to convert the pump and treat system to a passive treatment barrier system. Off-site groundwater concentrations have been reducing over time since installation of the pump and treat system in 2000 and injection of clean water beginning in 2003. However, localized areas of contaminated bedrock just beyond the property line continue to impact off-site groundwater. The modified work plan for addressing this condition includes converting the off-site bioremediation system into a monitoring well network and employing different remediation methods in these recalcitrant areas. In accordance with the work plan, a pilot test was conducted of certain groundwater remediation methods and the results of that test were used to develop more detailed plans for remedial activities in the off-site areas, which were approved by the authorities and are being implemented in a phased manner. The results of groundwater monitoring are being used to evaluate the effectiveness of these activities. The Company continues to implement the expanded remedy work plan that was approved by the oversight authorities in 2015. Based on the progress of the direct remedial action of on-site conditions, the Company submitted a request to the oversight authorities for permission to convert the perimeter pump and treat active remediation system to a passive one. In 2019, a final response was received from the oversight authorities, which is allowing the Company to proceed with implementation of the revised plan. The Company continues to work with outside experts and the oversight authorities on the off-site work plan. The cumulative expenditures for both on-site and off-site remediation through October 30, 2021 were $32.3 million. The Company has recovered a portion of these expenditures from insurers and other third parties. The reserve for the anticipated future remediation activities at October 30, 2021 is $9.9 million, of which $8.9 million is recorded within other liabilities and $1.0 million is recorded within other accrued expenses. Of the total $9.9 million reserve, $5.1 million is for off-site remediation and $4.8 million is for on-site remediation. The liability for the on-site remediation was discounted at 4.8%. On an undiscounted basis, the on-site remediation liability would be $13.7 million as of October 30, 2021. The Company expects to spend approximately $0.6 million in 2 0 21 Other Various federal and state authorities have identified the Company as a potentially responsible party for remediation at certain other sites. However, the Company does not currently believe that its liability for such sites, if any, would be material. The Company continues to evaluate its remediation plans in conjunction with its environmental consultants and records its best estimate of remediation liabilities. However, future actions and the associated costs are subject to oversight and approval of various governmental authorities. Accordingly, the ultimate costs may vary, and it is possible costs may exceed the recorded amounts. Litigation The Company is involved in legal proceedings and litigation arising in the ordinary course of business. In the opinion of management, the outcome of such ordinary course of business proceedings and litigation currently pending is not expected to have a material adverse effect on the Company’s results of operations or financial position. Legal costs associated with litigation are generally expensed as incurred.

Basis of Presentation and Gen_2

Basis of Presentation and General (Policies)	9 Months Ended
	Oct. 30, 2021
Basis of Presentation and General
Basis of Presentation	Basis of Presentation The accompanying condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q of the United States Securities and Exchange Commission (“SEC”) and reflect all adjustments and accruals of a normal recurring nature, which management believes are necessary to present fairly the financial position, results of operations, comprehensive income and cash flows of Caleres, Inc. ("the Company"). These statements, however, do not include all information and footnotes necessary for a complete presentation of the Company’s consolidated financial position, results of operations, comprehensive income and cash flows in conformity with accounting principles generally accepted in the United States. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries, after the elimination of intercompany accounts and transactions. ​ The Company’s business is seasonal in nature due to consumer spending patterns, with higher back-to-school and holiday season sales. Traditionally, the third fiscal quarter accounts for a substantial portion of the Company’s earnings for the year. Interim results may not necessarily be indicative of results which may be expected for any other interim period or for the year as a whole. Certain prior period amounts in the condensed consolidated financial statements and footnotes have been reclassified to conform to the current period presentation. These reclassifications did not affect net earnings (loss) attributable to Caleres, Inc. The accompanying condensed consolidated financial statements and footnotes should be read in conjunction with the consolidated financial statements and footnotes included in the Company’s Annual Report on Form 10-K for the year ended January 30, 2021.
Noncontrolling Interests	Noncontrolling Interests During 2019, the Company entered into a joint venture with Brand Investment Holding Limited (“Brand Investment Holding”), a member of the Gemkell Group. The Company and Brand Investment Holding are each 50% owners of the joint venture, which is named CLT Brand Solutions (“CLT”). Net sales and operating earnings were $4.7 million and $0.2 million, respectively, for the thirteen weeks and $14.5 million and $2.4 million, respectively, for the thirty-nine weeks ended October 30, 2021. Net sales and operating earnings were not significant during the thirteen or thirty-nine weeks ended October 31, 2020. The Company had a joint venture agreement with a subsidiary of C. banner International Holdings Limited (“CBI”) to market Naturalizer footwear in China. The Company was a 51% owner of the joint venture (“B&H Footwear”), with CBI owning the other 49%. The license enabling the joint venture to market the footwear expired in August 2017 and the parties are in the process of dissolving their joint venture agreements. The Company anticipates the liquidation to be completed during the fourth quarter of 2021. The Company consolidates CLT and B&H Footwear into its condensed consolidated financial statements. Net earnings (loss) attributable to noncontrolling interests represents the share of net earnings or losses that are attributable to Brand Investment Holding equity. Transactions between the Company and the joint ventures have been eliminated in the condensed consolidated financial statements.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
Derivative Financial Instruments	Derivative Financial Instruments The Company’s hedging policy permits the use of forward contracts as cash flow hedging instruments to manage its currency exposures in foreign currency-denominated assets, liabilities and cash flows. These derivative financial instruments are viewed as risk management tools and are not used for trading or speculative purposes. The Company recognizes all derivative financial instruments as either assets or liabilities in the condensed consolidated balance sheets and measures those instruments at fair value.
COVID-19 Pandemic	COVID-19 Pandemic The coronavirus (“COVID-19”) pandemic had a significant adverse impact on the United States economy and the retail industry. The Company’s financial results were negatively impacted during the first half of 2020 as a result of the temporary closure of all retail stores beginning in mid-March. The Company experienced sequential improvement in sales in the second half of 2020, driven by the reopening of the retail stores, and continued solid growth of the e-commerce business. During the first half of 2021, as the vaccines became widely distributed and governments continued to ease restrictions, consumer sentiment and spending began to improve. In addition, the additional stimulus measures approved by the federal government provided a boost in consumer spending. These factors strengthened demand for our products, which contributed to higher store traffic and strong growth in the Company’s net sales and operating earnings for the thirty-nine weeks ended October 30, 2021. On March 27, 2020, the Coronavirus Aid, Relief and Economic Security ("CARES") Act was enacted. The CARES Act includes a provision that allows the Company to defer the employer portion of social security payroll tax payments that would have been paid between the enactment date and December 31, 2020, with 50% payable by December 31, 2021 and 50% payable by December 31, 2022. During 2020, the Company deferred approximately $9.4 million of employer social security payroll taxes. As of October 30, 2021, approximately $4.7 million is recorded in other accrued expenses and $4.7 million is recorded in other liabilities on the condensed consolidated balance sheet. As of October 31, 2020, approximately $7.0 million was recorded in other liabilities on the condensed consolidated balance sheet.
Corporate Headquarters	Corporate Headquarters Campus In April 2021, the Company announced that it would begin marketing for sale its nine-acre corporate headquarters campus (the “Campus”) located in Clayton, Missouri. The Company continues to evaluate offers and explore relocation and redevelopment options. The Company does not anticipate the Campus to qualify as a completed sale within the next twelve months. Accordingly, as of October 30, 2021, the Campus is considered held and used and classified within property and equipment, net on the condensed consolidated balance sheets. In addition, the Company evaluated the Campus asset group for impairment indicators and determined that no indicators were present.

Revenues (Tables)

Revenues (Tables)	9 Months Ended
	Oct. 30, 2021
Revenues
Schedule of disaggregated revenue by segment and major source	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirteen Weeks Ended October 30, 2021 ​ ​ ​ ​ ​ ​ ​ ​ Eliminations and ​ ​ ​ ($ thousands) Famous Footwear Brand Portfolio Other Total ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Retail stores ​ $ 429,914 ​ $ 17,230 ​ $ — ​ $ 447,144 Landed wholesale - e-commerce - drop ship (1) ​ — ​ 22,054 ​ (644) ​ 21,410 E-commerce - Company websites (1) ​ 63,964 ​ 44,101 ​ — ​ 108,065 Total direct-to-consumer sales ​ ​ 493,878 ​ ​ 83,385 ​ ​ (644) ​ ​ 576,619 First-cost wholesale - e-commerce (1) ​ — ​ 567 ​ — ​ 567 Landed wholesale - e-commerce (1) ​ ​ — ​ ​ 46,842 ​ ​ — ​ ​ 46,842 Landed wholesale - other ​ — ​ 138,813 ​ (10,373) ​ 128,440 First-cost wholesale ​ — ​ 27,315 ​ — ​ 27,315 Licensing and royalty ​ 602 ​ 3,536 ​ — ​ 4,138 Other (2) ​ 180 ​ 55 ​ — ​ 235 Net sales ​ $ 494,660 ​ $ 300,513 ​ $ (11,017) ​ $ 784,156 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirteen Weeks Ended October 31, 2020 ​ ​ ​ ​ ​ ​ ​ ​ Eliminations and ​ ​ ​ ($ thousands) Famous Footwear Brand Portfolio Other Total ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Retail stores ​ $ 325,501 ​ $ 14,291 ​ $ — ​ $ 339,792 Landed wholesale - e-commerce - drop ship (1) ​ ​ — ​ ​ 21,256 ​ ​ — ​ ​ 21,256 E-commerce - Company websites (1) ​ 66,058 ​ 35,100 ​ — ​ 101,158 Total direct-to-consumer sales ​ ​ 391,559 ​ ​ 70,647 ​ ​ — ​ ​ 462,206 First-cost wholesale - e-commerce (1) ​ — ​ 99 ​ — ​ 99 Landed wholesale - e-commerce (1) ​ — ​ 42,001 ​ — ​ 42,001 Landed wholesale - other ​ — ​ 136,627 ​ (11,813) ​ 124,814 First-cost wholesale ​ — ​ 15,368 ​ — ​ 15,368 Licensing and royalty ​ — ​ 2,809 ​ — ​ 2,809 Other (2) ​ 147 ​ 36 ​ — ​ 183 Net sales ​ $ 391,706 ​ $ 267,587 ​ $ (11,813) ​ $ 647,480 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirty-Nine Weeks Ended October 30, 2021 ​ ​ ​ ​ ​ ​ ​ ​ Eliminations and ​ ​ ​ ($ thousands) Famous Footwear Brand Portfolio Other Total ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Retail stores ​ $ 1,166,837 ​ $ 44,241 ​ $ — ​ $ 1,211,078 Landed wholesale - e-commerce - drop ship (1) ​ — ​ 62,529 ​ (1,477) ​ 61,052 E-commerce - Company websites (1) ​ 178,367 ​ 136,458 ​ — ​ 314,825 Total direct-to-consumer sales ​ $ 1,345,204 ​ $ 243,228 ​ $ (1,477) ​ $ 1,586,955 First-cost wholesale - e-commerce (1) ​ — ​ 2,340 ​ — ​ 2,340 Landed wholesale - e-commerce (1) ​ ​ — ​ ​ 114,608 ​ ​ — ​ ​ 114,608 Landed wholesale - other ​ — ​ 353,597 ​ (36,445) ​ 317,152 First-cost wholesale ​ — ​ 67,651 ​ — ​ 67,651 Licensing and royalty ​ 602 ​ 8,302 ​ — ​ 8,904 Other (2) ​ 607 ​ 106 ​ — ​ 713 Total net sales ​ $ 1,346,413 ​ $ 789,832 ​ $ (37,922) ​ $ 2,098,323 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirty-Nine Weeks Ended October 31, 2020 ​ ​ ​ ​ ​ ​ ​ ​ Eliminations and ​ ​ ​ ($ thousands) Famous Footwear Brand Portfolio Other Total ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Retail stores ​ $ 712,761 ​ $ 33,173 ​ $ — ​ $ 745,934 Landed wholesale - e-commerce - drop ship (1) ​ ​ — ​ ​ 61,235 ​ ​ — ​ ​ 61,235 E-commerce - Company websites (1) ​ 203,888 ​ 108,926 ​ — ​ 312,814 Total direct-to-consumer sales ​ $ 916,649 ​ $ 203,334 ​ $ — ​ $ 1,119,983 First-cost wholesale - e-commerce (1) ​ — ​ 601 ​ — ​ 601 Landed wholesale - e-commerce (1) ​ ​ — ​ ​ 91,477 ​ ​ — ​ ​ 91,477 Landed wholesale - other ​ — ​ 327,322 ​ (39,229) ​ 288,093 First-cost wholesale ​ — ​ 39,139 ​ — ​ 39,139 Licensing and royalty ​ — ​ 6,463 ​ — ​ 6,463 Other (2) ​ 244 ​ 111 ​ — ​ 355 Net sales ​ $ 916,893 ​ $ 668,447 ​ $ (39,229) ​ $ 1,546,111 (1) Collectively referred to as "e-commerce" below (2) Includes breakage revenue from unredeemed gift cards
Schedule of significant contract balances from contracts with customers	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ($ thousands) October 30, 2021 October 31, 2020 January 30, 2021 Customer allowances and discounts ​ $ 20,277 ​ $ 22,182 ​ $ 17,043 Loyalty programs liability ​ 18,354 ​ 14,634 ​ 13,986 Returns reserve ​ 15,704 ​ 14,889 ​ 11,040 Gift card liability ​ 5,034 ​ 4,909 ​ 6,091
Schedule of allowance for expected credit losses	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirty-Nine Weeks Ended ($ thousands) October 30, 2021 ​ October 31, 2020 Balance, beginning of period ​ $ 14,928 ​ $ 1,813 Adjustment upon adoption of ASU 2016-13 ​ ​ — ​ ​ 2,521 Provision/adjustment for expected credit losses (1) ​ ​ (2,711) ​ ​ 10,663 Uncollectible accounts written off, net of recoveries ​ ​ (2,724) ​ ​ 221 Balance, end of period ​ $ 9,493 ​ $ 15,218 (1) The Company’s provision/adjustment for expected credit losses for the thirty-nine weeks ended October 31, 2020 was higher than the comparable period in 2021 as a result of the COVID-19 pandemic and its impact on the financial condition of several of the Company’s wholesale customers.

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	9 Months Ended
	Oct. 30, 2021
Earnings (Loss) Per Share
Schedule of earnings per share, basic and diluted	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirteen Weeks Ended ​ Thirty-Nine Weeks Ended ($ thousands, except per share amounts) October 30, 2021 October 31, 2020 October 30, 2021 October 31, 2020 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ NUMERATOR ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net earnings (loss) ​ $ 59,685 ​ $ 14,926 ​ $ 104,222 ​ $ (361,915) Net earnings attributable to noncontrolling interests ​ (63) ​ (509) ​ (1,057) ​ (223) Net earnings (loss) attributable to Caleres, Inc. ​ $ 59,622 ​ $ 14,417 ​ $ 103,165 ​ $ (362,138) Net earnings allocated to participating securities ​ (2,140) ​ (512) ​ (3,737) ​ — Net earnings (loss) attributable to Caleres, Inc. after allocation of earnings to participating securities ​ $ 57,482 ​ $ 13,905 ​ $ 99,428 ​ $ (362,138) ​ ​ ​ ​ ​ DENOMINATOR ​ ​ ​ ​ Denominator for basic earnings (loss) per common share attributable to Caleres, Inc. shareholders ​ 36,889 ​ 36,554 ​ 36,825 ​ 37,439 Dilutive effect of share-based awards ​ 457 ​ 176 ​ 294 ​ — Denominator for diluted earnings (loss) per common share attributable to Caleres, Inc. shareholders ​ 37,346 ​ 36,730 ​ 37,119 ​ 37,439 ​ ​ ​ ​ ​ Basic earnings (loss) per common share attributable to Caleres, Inc. shareholders ​ $ 1.56 ​ $ 0.38 ​ $ 2.70 ​ $ (9.67) ​ ​ ​ ​ ​ Diluted earnings (loss) per common share attributable to Caleres, Inc. shareholders ​ $ 1.54 ​ $ 0.38 ​ $ 2.68 ​ $ (9.67)

Business Segment Information (T

Business Segment Information (Tables)	9 Months Ended
	Oct. 30, 2021
Business Segment Information
Schedule of segment reporting information, by segment	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Famous ​ Brand ​ Eliminations ​ ​ ​ ($ thousands) Footwear Portfolio and Other Total Thirteen Weeks Ended October 30, 2021 ​ ​ ​ ​ ​ ​ ​ ​ Net sales ​ $ 494,660 ​ $ 300,513 ​ $ (11,017) ​ $ 784,156 Intersegment sales (1) ​ — ​ ​ 11,017 ​ ​ — ​ 11,017 Operating earnings (loss) ​ 87,375 ​ 11,383 ​ (17,440) ​ 81,318 Segment assets ​ 736,858 ​ 909,175 ​ 228,525 ​ 1,874,558 ​ ​ ​ ​ ​ Thirteen Weeks Ended October 31, 2020 ​ ​ ​ ​ Net sales ​ $ 391,706 ​ $ 267,587 ​ $ (11,813) ​ $ 647,480 Intersegment sales (1) ​ — ​ 11,813 ​ — ​ 11,813 Operating earnings (loss) ​ 27,845 ​ 7,304 ​ (15,078) ​ 20,071 Segment assets ​ 837,228 ​ 924,976 ​ 264,856 ​ 2,027,060 ​ ​ ​ ​ ​ Thirty-Nine Weeks Ended October 30, 2021 ​ ​ ​ ​ ​ ​ ​ ​ Net sales ​ $ 1,346,413 ​ $ 789,832 ​ $ (37,922) ​ $ 2,098,323 Intersegment sales (1) ​ — ​ 37,922 ​ — ​ 37,922 Operating earnings (loss) ​ 220,746 ​ 25,116 ​ (83,883) ​ 161,979 ​ ​ ​ ​ ​ Thirty-Nine Weeks Ended October 31, 2020 ​ ​ ​ ​ Net sales ​ $ 916,893 ​ $ 668,447 ​ $ (39,229) ​ $ 1,546,111 Intersegment sales (1) ​ — ​ 39,229 ​ — ​ 39,229 Operating loss ​ (38,651) ​ (352,556) ​ (39,072) ​ (430,279) (1) Included in net sales in the Brand Portfolio segment and eliminated in the Eliminations and Other category.
Reconciliation of operating profit (loss) from segments to consolidated	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirteen Weeks Ended ​ Thirty-Nine Weeks Ended ($ thousands) October 30, 2021 October 31, 2020 October 30, 2021 October 31, 2020 Operating earnings (loss) ​ $ 81,318 ​ $ 20,071 ​ $ 161,979 ​ $ (430,279) Interest expense, net ​ (5,069) ​ (10,881) ​ (28,803) ​ (33,747) Loss on early extinguishment of debt ​ (649) ​ — ​ (649) ​ — Other income, net ​ 3,844 ​ 5,461 ​ 11,533 ​ 12,718 Earnings (loss) before income taxes ​ $ 79,444 ​ $ 14,651 ​ $ 144,060 ​ $ (451,308)

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Oct. 30, 2021
Inventories
Schedule of inventory, current	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ($ thousands) October 30, 2021 October 31, 2020 January 30, 2021 Raw materials ​ $ 14,951 ​ $ 14,907 ​ $ 14,592 Work-in-process ​ 581 ​ 293 ​ 349 Finished goods ​ 527,686 ​ 492,165 ​ 473,014 Inventories, net ​ $ 543,218 ​ $ 507,365 ​ $ 487,955

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Oct. 30, 2021
Goodwill and Intangible Assets
Schedule of intangible assets and goodwill	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ($ thousands) October 30, 2021 October 31, 2020 January 30, 2021 Intangible Assets ​ ​ ​ Famous Footwear ​ $ 2,800 ​ $ 2,800 ​ $ 2,800 Brand Portfolio ​ 342,083 ​ 365,888 ​ 342,083 Total intangible assets ​ 344,883 ​ 368,688 ​ 344,883 Accumulated amortization ​ (119,214) ​ (106,570) ​ (109,768) Total intangible assets, net ​ 225,669 ​ 262,118 ​ 235,115 Goodwill ​ ​ ​ Brand Portfolio (1) ​ 4,956 ​ 4,956 ​ 4,956 Total goodwill ​ 4,956 ​ 4,956 ​ 4,956 Goodwill and intangible assets, net ​ $ 230,625 ​ $ 267,074 ​ $ 240,071 (1) The carrying amount of goodwill as of October 30, 2021, October 31, 2020 and January 30, 2021 is presented net of accumulated impairment charges of $415.7 million.
Schedule of finite-lived and indefinite lived intangible assets	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ($ thousands) October 30, 2021 ​ Estimated Useful Lives ​ ​ Accumulated Accumulated ​ ​ ​ ​ (In Years) ​ Cost Basis (2) ​ Amortization ​ Impairment ​ Net Carrying Value Trade names 2 - 40 ​ $ 299,488 ​ $ 109,545 ​ $ 10,200 ​ $ 179,743 Trade names Indefinite ​ 107,400 ​ — ​ 92,000 ​ 15,400 Customer relationships 15 - 16 44,200 9,669 4,005 30,526 ​ ​ ​ ​ $ 451,088 ​ $ 119,214 ​ $ 106,205 ​ $ 225,669 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ October 31, 2020 ​ Estimated Useful Lives ​ ​ Accumulated Accumulated ​ ​ ​ ​ (In Years) ​ Cost Basis (2) ​ Amortization ​ Impairment ​ Net Carrying Value Trade names 2 - 40 ​ $ 299,488 ​ $ 99,376 ​ $ 10,200 ​ $ 189,912 Trade names Indefinite ​ 107,400 ​ — ​ 72,200 ​ 35,200 Customer relationships 15 - 16 44,200 7,194 — 37,006 ​ ​ ​ ​ $ 451,088 ​ $ 106,570 ​ $ 82,400 ​ $ 262,118 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ January 30, 2021 ​ Estimated Useful Lives ​ ​ Accumulated Accumulated ​ ​ ​ ​ (In Years) ​ Cost Basis (2) ​ Amortization ​ Impairment ​ Net Carrying Value Trade names 2 - 40 ​ $ 299,488 ​ $ 101,919 ​ $ 10,200 ​ $ 187,369 Trade names Indefinite ​ 107,400 ​ — ​ 92,000 ​ 15,400 Customer relationships 15 - 16 44,200 7,849 4,005 32,346 ​ ​ ​ ​ $ 451,088 ​ $ 109,768 ​ $ 106,205 ​ $ 235,115 (2) The Via Spiga trade name was reclassified from indefinite-lived trade names to definite-lived trade names. The remaining carrying value of $0.1 million as of October 30, 2021 will be fully amortized by the end of fiscal 2021.

Leases (Tables)

Leases (Tables)	9 Months Ended
	Oct. 30, 2021
Leases
Schedule of components of lease expenses	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirteen Weeks Ended ($ thousands) ​ October 30, 2021 October 31, 2020 Operating lease expense $ 35,140 $ 38,568 Variable lease expense ​ 10,982 ​ 12,739 Short-term lease expense ​ 737 ​ 1,775 Sublease income ​ (419) ​ (29) Total lease expense ​ $ 46,440 ​ $ 53,053 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirty-Nine Weeks Ended ($ thousands) ​ October 30, 2021 October 31, 2020 Operating lease expense $ 112,838 $ 124,906 Variable lease expense ​ 30,985 ​ 36,090 Short-term lease expense ​ 2,011 ​ 3,872 Sublease income ​ (477) ​ (76) Total lease expense ​ $ 145,357 ​ $ 164,792
Schedule of supplemental cash flow information related to leases	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirty-Nine Weeks Ended ($ thousands) October 30, 2021 October 31, 2020 Cash paid for lease liabilities (1) ​ $ 140,930 ​ $ 99,517 Cash received from sublease income ​ 477 ​ 76 ​ (1) Cash paid for lease liabilities for the thirty-nine weeks ended October 30, 2021 includes payment of certain lease payments deferred in 2020, as described above, as well as lease termination costs associated with the Naturalizer retail store closings, as further discussed in Note 5 to the condensed consolidated financial statements. In addition, cash paid for lease liabilities during the thirty-nine weeks ended October 31, 2020 was significantly lower than comparable periods, reflecting the deferral of lease payments during the onset of the pandemic.

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	9 Months Ended
	Oct. 30, 2021
Shareholders' Equity
Schedule of accumulated other comprehensive income (loss)	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Pension and Derivative ​ ​ ​ ​ ​ ​ ​ Other ​ Financial ​ Accumulated ​ ​ Foreign ​ Postretirement ​ Instrument ​ Other ​ ​ Currency ​ Transactions ​ Transactions ​ Comprehensive ($ thousands) ​ Translation ​ (1) ​ (2) ​ (Loss) Income Balance at July 31, 2021 ​ $ (260) ​ $ (8,312) ​ $ — ​ $ (8,572) Other comprehensive loss before reclassifications ​ ​ (257) ​ ​ — ​ ​ — ​ ​ (257) Reclassifications: ​ ​ ​ ​ ​ ​ ​ ​ Amounts reclassified from accumulated other comprehensive loss ​ ​ — ​ ​ 445 ​ ​ — ​ ​ 445 Tax benefit ​ — ​ (87) ​ — ​ (87) Net reclassifications ​ — ​ 358 ​ — ​ 358 Other comprehensive (loss) income ​ (257) ​ 358 ​ — ​ 101 Balance at October 30, 2021 ​ $ (517) ​ $ (7,954) ​ $ — ​ $ (8,471) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Balance at August 1, 2020 ​ $ (1,390) ​ $ (30,047) ​ $ — ​ $ (31,437) Other comprehensive income before reclassifications ​ 320 ​ — ​ — ​ 320 Reclassifications: ​ ​ ​ ​ Amounts reclassified from accumulated other comprehensive loss ​ — ​ (111) ​ — ​ (111) Tax provision (3) ​ — ​ 44 ​ — ​ 44 Net reclassifications ​ — ​ (67) ​ — ​ (67) Other comprehensive income (loss) ​ 320 ​ (67) ​ — ​ 253 Balance at October 31, 2020 ​ $ (1,070) ​ $ (30,114) ​ $ — ​ $ (31,184) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Balance at January 30, 2021 ​ $ (111) ​ $ (9,025) ​ $ — ​ $ (9,136) Other comprehensive loss before reclassifications ​ (406) ​ — ​ — ​ (406) Reclassifications: ​ ​ ​ ​ ​ Amounts reclassified from accumulated other comprehensive loss ​ — ​ 1,340 ​ — ​ 1,340 Tax benefit ​ — ​ (269) ​ — ​ (269) Net reclassifications ​ — ​ 1,071 ​ — ​ 1,071 Other comprehensive (loss) income ​ (406) ​ 1,071 ​ — ​ 665 Balance at October 30, 2021 ​ $ (517) ​ $ (7,954) ​ $ — ​ $ (8,471) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Balance at February 1, 2020 ​ $ (580) ​ $ (31,171) ​ $ (92) ​ $ (31,843) Other comprehensive (loss) income before reclassifications ​ (490) ​ — ​ 87 ​ (403) Reclassifications: ​ ​ ​ ​ Amounts reclassified from accumulated other comprehensive loss ​ — ​ 1,393 ​ 6 ​ 1,399 Tax benefit (3) ​ — ​ (336) ​ (1) ​ (337) Net reclassifications ​ — ​ 1,057 ​ 5 ​ 1,062 Other comprehensive (loss) income ​ (490) ​ 1,057 ​ 92 ​ 659 Balance at October 31, 2020 ​ $ (1,070) ​ $ (30,114) ​ $ — ​ $ (31,184) (1) Amounts reclassified are included in other income, net. Refer to Note 13 to the condensed consolidated financial statements for additional information related to pension and other postretirement benefits. (2) Amounts reclassified are included in net sales, costs of goods sold and selling and administrative expenses. Refer to Note 1 to the condensed consolidated financial statements for additional information related to derivative financial instruments . (3) Includes approximately $0.5 million of expense related to a valuation allowance on net deferred taxes, including those related to other comprehensive income, for the Company’s Canadian subsidiary.

Share-Based Compensation (Table

Share-Based Compensation (Tables)	9 Months Ended
	Oct. 30, 2021
Share-Based Compensation
Share-based payment arrangement, restricted stock and restricted stock unit, activity	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirteen Weeks Ended ​ ​ ​ Thirteen Weeks Ended ​ ​ October 30, 2021 ​ ​ ​ October 31, 2020 ​ ​ ​ ​ ​ Weighted- ​ ​ ​ ​ ​ ​ Weighted- ​ ​ Total Number ​ ​ Average ​ ​ ​ Total Number ​ ​ Average ​ ​ of Restricted ​ ​ Grant Date ​ ​ ​ of Restricted ​ ​ Grant Date ​ Shares ​ Fair Value ​ Shares ​ Fair Value July 31, 2021 ​ 1,380,246 ​ $ 14.05 ​ August 1, 2020 ​ 1,360,602 ​ $ 17.81 Granted ​ — ​ ​ — ​ Granted ​ 35,000 ​ ​ 9.73 Forfeited ​ (9,500) ​ ​ 15.72 ​ Forfeited ​ (875) ​ ​ 14.51 Vested (3,500) ​ 26.42 Vested (6,500) ​ 25.18 October 30, 2021 1,367,246 ​ $ 14.01 ​ October 31, 2020 1,388,227 ​ $ 17.57 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirty-Nine Weeks Ended ​ ​ ​ Thirty-Nine Weeks Ended ​ October 30, 2021 ​ October 31, 2020 ​ ​ ​ ​ Weighted- ​ ​ ​ ​ ​ Weighted- ​ ​ Total Number ​ Average ​ ​ ​ Total Number ​ Average ​ ​ of Restricted ​ Grant Date ​ ​ ​ of Restricted ​ Grant Date ​ ​ Shares ​ Fair Value ​ ​ ​ Shares ​ Fair Value January 30, 2021 1,397,227 ​ $ 16.74 ​ February 1, 2020 1,271,795 ​ $ 26.77 Granted 568,916 ​ 18.73 ​ Granted 598,431 ​ 6.14 Forfeited (78,375) ​ 15.48 ​ Forfeited (68,787) ​ 23.11 Vested (520,522) ​ 26.26 ​ Vested (413,212) ​ 28.23 October 30, 2021 1,367,246 ​ $ 14.01 ​ October 31, 2020 1,388,227 ​ $ 17.57

Retirement and Other Benefit _2

Retirement and Other Benefit Plans (Tables)	9 Months Ended
	Oct. 30, 2021
Notes Tables
Schedule of net benefit costs	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Pension Benefits ​ Other Postretirement Benefits ​ Thirteen Weeks Ended Thirteen Weeks Ended ($ thousands) ​ October 30, 2021 October 31, 2020 October 30, 2021 October 31, 2020 Service cost ​ $ 1,872 ​ $ 2,005 ​ $ — ​ $ — Interest cost ​ 2,811 ​ 2,970 ​ 8 ​ 10 Expected return on assets ​ (7,108) ​ (8,330) ​ — ​ — Amortization of: ​ ​ ​ ​ ​ ​ Actuarial loss (gain) ​ 601 ​ 240 ​ (27) ​ (27) Prior service income ​ (129) ​ (324) ​ — ​ — Total net periodic benefit income ​ $ (1,953) ​ $ (3,439) ​ $ (19) ​ $ (17) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Pension Benefits ​ Other Postretirement Benefits ​ Thirty-Nine Weeks Ended Thirty-Nine Weeks Ended ($ thousands) October 30, 2021 October 31, 2020 October 30, 2021 October 31, 2020 Service cost ​ $ 5,615 ​ $ 6,412 ​ $ — ​ $ — Interest cost ​ 8,430 ​ 9,252 ​ 28 ​ 31 Expected return on assets ​ (21,331) ​ (23,205) ​ — ​ — Amortization of: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Actuarial loss (gain) ​ 1,808 ​ 2,506 ​ (82) ​ (82) Prior service income ​ (386) ​ (1,031) ​ — ​ — Settlement cost ​ — ​ 222 ​ — ​ — Curtailment gain ​ — ​ (189) ​ — ​ — Total net periodic benefit income ​ $ (5,864) ​ $ (6,033) ​ $ (54) ​ $ (51) ​

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 30, 2021
Fair Value Measurements
Schedule of fair value, assets and liabilities measured on recurring basis	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fair Value Measurements ($ thousands) Total Level 1 Level 2 Level 3 Asset (Liability) ​ ​ ​ ​ ​ ​ ​ ​ October 30, 2021: ​ ​ ​ ​ ​ ​ ​ ​ Cash equivalents – money market funds ​ $ 35,000 ​ $ 35,000 ​ $ — ​ $ — Non-qualified deferred compensation plan assets ​ 7,789 ​ 7,789 ​ — ​ ​ — Non-qualified deferred compensation plan liabilities ​ (7,789) ​ (7,789) ​ — ​ ​ — Deferred compensation plan liabilities for non-employee directors ​ (1,764) ​ (1,764) ​ — ​ ​ — Restricted stock units for non-employee directors ​ (2,558) ​ (2,558) ​ — ​ ​ — Mandatory purchase obligation - Blowfish Malibu ​ (54,558) ​ — ​ — ​ ​ (54,558) October 31, 2020: ​ ​ ​ ​ ​ ​ ​ ​ Cash equivalents – money market funds ​ $ 82,500 ​ $ 82,500 ​ $ — ​ $ — Non-qualified deferred compensation plan assets ​ ​ 7,741 ​ ​ 7,741 ​ ​ — ​ ​ — Non-qualified deferred compensation plan liabilities ​ (7,741) ​ (7,741) ​ — ​ ​ — Deferred compensation plan liabilities for non-employee directors ​ (813) ​ (813) ​ — ​ ​ — Restricted stock units for non-employee directors ​ (840) ​ (840) ​ — ​ ​ — Mandatory purchase obligation - Blowfish Malibu ​ (30,146) ​ — ​ — ​ ​ (30,146) January 30, 2021: ​ ​ ​ ​ ​ ​ ​ ​ Cash equivalents – money market funds ​ $ 45,000 ​ $ 45,000 ​ $ — ​ $ — Non-qualified deferred compensation plan assets ​ 7,918 ​ 7,918 ​ — ​ ​ — Non-qualified deferred compensation plan liabilities ​ (7,918) ​ (7,918) ​ — ​ ​ — Deferred compensation plan liabilities for non-employee directors ​ (989) ​ (989) ​ — ​ ​ — Restricted stock units for non-employee directors ​ (1,661) ​ (1,661) ​ — ​ ​ — Mandatory purchase obligation - Blowfish Malibu ​ (39,134) ​ — ​ — ​ ​ (39,134)
Details of long-lived asset impairment charges	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Thirteen Weeks Ended ​ Thirty-Nine Weeks Ended ($ thousands) October 30, 2021 October 31, 2020 October 30, 2021 October 31, 2020 Long-Lived Asset Impairment Charges ​ ​ ​ ​ Famous Footwear ​ $ 400 ​ $ — ​ $ 1,200 ​ $ 14,896 Brand Portfolio ​ 711 ​ 398 ​ 2,199 ​ 20,724 Total long-lived asset impairment charges ​ $ 1,111 ​ $ 398 ​ $ 3,399 ​ $ 35,620
Fair value, by balance Sheet grouping	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ October 30, 2021 October 31, 2020 January 30, 2021 ​ ​ Carrying ​ ​ ​ ​ Carrying ​ ​ ​ ​ Carrying ​ ​ ​ ($ thousands) Value (1) Fair Value Value (1) Fair Value Value (1) Fair Value Borrowings under revolving credit agreement ​ $ 175,000 ​ $ 175,000 ​ $ 300,000 ​ $ 300,000 ​ $ 250,000 ​ $ 250,000 Current portion of long-term debt ​ ​ 100,000 ​ ​ 100,000 ​ ​ — ​ ​ — ​ ​ — ​ ​ — Long-term debt ​ — ​ — ​ 200,000 ​ 188,750 ​ 200,000 ​ 201,000 Total debt ​ $ 275,000 ​ $ 275,000 ​ $ 500,000 ​ $ 488,750 ​ $ 450,000 ​ $ 451,000 (1) Excludes unamortized debt issuance costs and debt discount

Basis of Presentation and Gen_3

Basis of Presentation and General (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020	Jan. 30, 2021
Basis of Presentation
Net sales	$ 784,156	$ 647,480	$ 2,098,323	$ 1,546,111
Operating earnings	81,318	20,071	161,979	(430,279)
Deferred employer social security payroll taxes, CARES Act					$ 9,400
Other Accrued Liabilities
Basis of Presentation
Deferred employer social security payroll taxes, CARES Act	4,700		4,700
Other Noncurrent Liabilities
Basis of Presentation
Deferred employer social security payroll taxes, CARES Act	$ 4,700	$ 7,000	$ 4,700	$ 7,000
CLT Brand Solutions
Basis of Presentation
Percentage of joint venture	50.00%		50.00%
Net sales	$ 4,700		$ 14,500
Operating earnings	$ 200		$ 2,400
B&H Footwear
Basis of Presentation
Percentage of joint venture	51.00%		51.00%
B&H Footwear | C. banner International Holdings Limited
Basis of Presentation
Noncontrolling interest, ownership percentage by noncontrolling owners	49.00%		49.00%

Revenues - Disaggregation of Re

Revenues - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Revenues
Net sales	$ 784,156	$ 647,480	$ 2,098,323	$ 1,546,111
Famous Footwear
Revenues
Net sales	494,660	391,706	1,346,413	916,893
Brand Portfolio
Revenues
Net sales	300,513	267,587	789,832	668,447
Eliminations and Other
Revenues
Net sales	(11,017)	(11,813)	(37,922)	(39,229)
Retail stores
Revenues
Net sales	447,144	339,792	1,211,078	745,934
Retail stores | Famous Footwear
Revenues
Net sales	429,914	325,501	1,166,837	712,761
Retail stores | Brand Portfolio
Revenues
Net sales	17,230	14,291	44,241	33,173
Retail stores | Eliminations and Other
Revenues
Net sales	0	0	0	0
Landed wholesale - E-commerce / drop ship
Revenues
Net sales	21,410	21,256	61,052	61,235
Landed wholesale - E-commerce / drop ship | Famous Footwear
Revenues
Net sales	0	0	0	0
Landed wholesale - E-commerce / drop ship | Brand Portfolio
Revenues
Net sales	22,054	21,256	62,529	61,235
Landed wholesale - E-commerce / drop ship | Eliminations and Other
Revenues
Net sales	(644)	0	(1,477)	0
E-commerce - Company websites
Revenues
Net sales	108,065	101,158	314,825	312,814
E-commerce - Company websites | Famous Footwear
Revenues
Net sales	63,964	66,058	178,367	203,888
E-commerce - Company websites | Brand Portfolio
Revenues
Net sales	44,101	35,100	136,458	108,926
E-commerce - Company websites | Eliminations and Other
Revenues
Net sales	0	0	0	0
Direct to consumer
Revenues
Net sales	576,619	462,206	1,586,955	1,119,983
Direct to consumer | Famous Footwear
Revenues
Net sales	493,878	391,559	1,345,204	916,649
Direct to consumer | Brand Portfolio
Revenues
Net sales	83,385	70,647	243,228	203,334
Direct to consumer | Eliminations and Other
Revenues
Net sales	(644)	0	(1,477)	0
First-cost wholesale - e-commerce
Revenues
Net sales	567	99	2,340	601
First-cost wholesale - e-commerce | Famous Footwear
Revenues
Net sales	0	0	0	0
First-cost wholesale - e-commerce | Brand Portfolio
Revenues
Net sales	567	99	2,340	601
First-cost wholesale - e-commerce | Eliminations and Other
Revenues
Net sales	0	0	0	0
Landed wholesale - e-commerce
Revenues
Net sales	46,842	42,001	114,608	91,477
Landed wholesale - e-commerce | Famous Footwear
Revenues
Net sales	0	0	0	0
Landed wholesale - e-commerce | Brand Portfolio
Revenues
Net sales	46,842	42,001	114,608	91,477
Landed wholesale - e-commerce | Eliminations and Other
Revenues
Net sales	0	0	0	0
Landed wholesale - other
Revenues
Net sales	128,440	124,814	317,152	288,093
Landed wholesale - other | Famous Footwear
Revenues
Net sales	0	0	0	0
Landed wholesale - other | Brand Portfolio
Revenues
Net sales	138,813	136,627	353,597	327,322
Landed wholesale - other | Eliminations and Other
Revenues
Net sales	(10,373)	(11,813)	(36,445)	(39,229)
First-cost wholesale
Revenues
Net sales	27,315	15,368	67,651	39,139
First-cost wholesale | Famous Footwear
Revenues
Net sales	0	0	0	0
First-cost wholesale | Brand Portfolio
Revenues
Net sales	27,315	15,368	67,651	39,139
First-cost wholesale | Eliminations and Other
Revenues
Net sales	0	0	0	0
Licensing and royalty
Revenues
Net sales	4,138	2,809	8,904	6,463
Licensing and royalty | Famous Footwear
Revenues
Net sales	602	0	602	0
Licensing and royalty | Brand Portfolio
Revenues
Net sales	3,536	2,809	8,302	6,463
Licensing and royalty | Eliminations and Other
Revenues
Net sales	0	0	0	0
Other
Revenues
Net sales	235	183	713	355
Other | Famous Footwear
Revenues
Net sales	180	147	607	244
Other | Brand Portfolio
Revenues
Net sales	55	36	106	111
Other | Eliminations and Other
Revenues
Net sales	$ 0	$ 0	$ 0	$ 0

Revenues - Contract Balances (D

Revenues - Contract Balances (Details) - USD ($) $ in Thousands	Oct. 30, 2021	Jan. 30, 2021	Oct. 31, 2020
Revenues
Customer allowances and discounts	$ 20,277	$ 17,043	$ 22,182
Loyalty programs liability	18,354	13,986	14,634
Returns reserve	15,704	11,040	14,889
Gift card liability	$ 5,034	$ 6,091	$ 4,909

Revenues (Details)

Revenues (Details) - Loyalty Program - USD ($) $ in Millions	9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020
Revenues
Contract with customer, liability, increase due to points and material rights earned on purchases	$ 27.4	$ 20.7
Contract with customer, liability, decrease due to expirations and redemptions	$ 23	$ 22.5

Revenues - Allowance for Expect

Revenues - Allowance for Expected Credit Losses (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Balance, beginning of period	$ 14,928	$ 1,813
Provision/adjustment for expected credit losses	(2,711)	10,663
Uncollectible accounts written off, net of recoveries	(2,724)	221
Balance, end of period	$ 9,493	15,218
Cumulative effect adjustment | Accounting Standards Update 2016-13 (ASC 326)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Balance, beginning of period		$ 2,521

Earnings (Loss) Per Share (Deta

Earnings (Loss) Per Share (Details) - shares	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Earnings (Loss) Per Share
Antidilutive securities excluded from computation of earnings per share, amount	16,667	24,667	16,667	24,667
Stock Repurchase Program
Earnings (Loss) Per Share
Treasury stock, shares, acquired (in shares)		0	0	2,902,122
Stock Repurchase Program, 2018
Earnings (Loss) Per Share
Stock repurchase program, number of shares authorized to be repurchased		2,500,000		2,500,000
Stock Repurchase Program, 2019
Earnings (Loss) Per Share
Stock repurchase program, number of shares authorized to be repurchased		5,000,000		5,000,000

Earnings (Loss) Per Share - Sch

Earnings (Loss) Per Share - Schedule of Basic and Diluted Earnings Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Earnings (Loss) Per Share
Net earnings (loss)	$ 59,685	$ 14,926	$ 104,222	$ (361,915)
Net earnings attributable to noncontrolling interests	(63)	(509)	(1,057)	(223)
Net earnings (loss) attributable to Caleres, Inc.	59,622	14,417	103,165	(362,138)
Net earnings allocated to participating securities	(2,140)	(512)	(3,737)
Net earnings (loss) attributable to Caleres, Inc. after allocation of earnings to participating securities	$ 57,482	$ 13,905	$ 99,428	$ (362,138)
Denominator for basic earnings (loss) per common share attributable to Caleres, Inc. shareholders	36,889	36,554	36,825	37,439
Dilutive effect of share-based awards (in shares)	457	176	294
Denominator for diluted earnings (loss) per common share attributable to Caleres, Inc. shareholders	37,346	36,730	37,119	37,439
Basic earnings (loss) per common share attributable to Caleres, Inc. shareholders	$ 1.56	$ 0.38	$ 2.70	$ (9.67)
Diluted earnings (loss) per common share attributable to Caleres, Inc. shareholders	$ 1.54	$ 0.38	$ 2.68	$ (9.67)

Restructuring and Other Speci_2

Restructuring and Other Special Charges (Details) $ / shares in Units, $ in Thousands	3 Months Ended			6 Months Ended	9 Months Ended
	Oct. 30, 2021USD ($)$ / shares	May 01, 2021store	Oct. 31, 2020USD ($)$ / shares	Jul. 31, 2021	Oct. 30, 2021USD ($)$ / shares	Oct. 31, 2020USD ($)$ / shares	Jul. 06, 2018USD ($)
Restructuring and Other Special Charges
Fair value adjustments of mandatory purchase obligation	$ 1,900		$ 5,100		$ 15,424	$ 14,946
Blowfish, LLC
Restructuring and Other Special Charges
Period after which noncontrolling interest is subject to the mandatory purchase obligation				3 years
Business acquisitions purchase obligation	54,600				54,600		$ 9,000
Fair value adjustments of mandatory purchase obligation	1,900		5,100		15,400	14,900
Fair value adjustments of mandatory purchase obligation, after tax basis	$ 1,400		$ 3,800		$ 11,500	$ 11,100
Fair value adjustments of mandatory purchase obligation, per diluted share (in dollars per share) | $ / shares	$ 0.04		$ 0.10		$ 0.30	$ 0.30
Brand Portfolio | Naturalizer Store Closings | Restructuring and Other Special Charges
Restructuring and Other Special Charges
Number of retail stores closed | store		73
Restructuring reserve	$ 2,500				$ 2,500
Brand Portfolio | Cost of Sales | Fergie Brand Exit | Inventory Mark downs
Restructuring and Other Special Charges
Total restructuring costs						$ 1,600
Restructuring costs, after-tax basis						$ 1,200
Restructuring and related cost, incurred cost, per diluted share | $ / shares						$ 0.03
Brand Portfolio | Restructuring and Other Special Charges | Naturalizer Store Closings | Restructuring and Other Special Charges
Restructuring and Other Special Charges
Total restructuring costs					13,500
Restructuring costs, after-tax basis					$ 11,900
Restructuring and related cost, incurred cost, per diluted share | $ / shares					$ 0.31
COVID-19
Restructuring and Other Special Charges
Restructuring and related cost, incurred cost, per diluted share | $ / shares						$ 2.08
Restructuring and related costs, incurred cost, total					$ 0	$ 99,000
Restructuring and related cost, incurred cost, after tax						78,000
COVID-19 | Cost of Sales
Restructuring and Other Special Charges
Inventory write-down						33,400
COVID-19 | Restructuring and Other Special Charges
Restructuring and Other Special Charges
Restructuring and related costs, incurred cost, total						65,600
COVID-19 | Brand Portfolio | Cost of Sales
Restructuring and Other Special Charges
Inventory write-down						27,400
COVID-19 | Brand Portfolio | Restructuring and Other Special Charges
Restructuring and Other Special Charges
Restructuring and related costs, incurred cost, total						48,400
COVID-19 | Famous Footwear | Cost of Sales
Restructuring and Other Special Charges
Inventory write-down						6,000
COVID-19 | Famous Footwear | Restructuring and Other Special Charges
Restructuring and Other Special Charges
Restructuring and related costs, incurred cost, total						16,600
COVID-19 | Eliminations and Other | Restructuring and Other Special Charges
Restructuring and Other Special Charges
Restructuring and related costs, incurred cost, total						$ 600

Business Segment Information -

Business Segment Information - Key Financial Measures (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020	Jan. 30, 2021
Business Segment Information - Key Financial Measures
Net sales	$ 784,156	$ 647,480	$ 2,098,323	$ 1,546,111
Intersegment sales	11,017	11,813	37,922	39,229
Operating earnings (loss)	81,318	20,071	161,979	(430,279)
Segment assets	1,874,558	2,027,060	1,874,558	2,027,060	$ 1,867,050
Famous Footwear
Business Segment Information - Key Financial Measures
Net sales	494,660	391,706	1,346,413	916,893
Operating earnings (loss)	87,375	27,845	220,746	(38,651)
Segment assets	736,858	837,228	736,858	837,228
Brand Portfolio
Business Segment Information - Key Financial Measures
Net sales	300,513	267,587	789,832	668,447
Intersegment sales	11,017	11,813	37,922	39,229
Operating earnings (loss)	11,383	7,304	25,116	(352,556)
Segment assets	909,175	924,976	909,175	924,976
Eliminations and Other
Business Segment Information - Key Financial Measures
Net sales	(11,017)	(11,813)	(37,922)	(39,229)
Operating earnings (loss)	(17,440)	(15,078)	(83,883)	(39,072)
Segment assets	$ 228,525	$ 264,856	$ 228,525	$ 264,856

Business Segment Information _2

Business Segment Information - Reconciliation of Operating Earnings Before Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Business Segment Information
Operating earnings (loss)	$ 81,318	$ 20,071	$ 161,979	$ (430,279)
Interest expense, net	(5,069)	(10,881)	(28,803)	(33,747)
Loss on early extinguishment of debt	(649)	0	(649)	0
Other income, net	3,844	5,461	11,533	12,718
Earnings (loss) before income taxes	$ 79,444	$ 14,651	$ 144,060	$ (451,308)

Inventories - Schedule of Inven

Inventories - Schedule of Inventories (Details) - USD ($) $ in Thousands	Oct. 30, 2021	Jan. 30, 2021	Oct. 31, 2020
Inventories
Raw materials	$ 14,951	$ 14,592	$ 14,907
Work-in-process	581	349	293
Finished goods	527,686	473,014	492,165
Inventories, net	$ 543,218	$ 487,955	$ 507,365

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Details) - USD ($) $ in Thousands	Nov. 01, 2020	Oct. 30, 2021	Oct. 31, 2020	Aug. 01, 2020	May 02, 2020	Oct. 30, 2021	Oct. 31, 2020	Jan. 30, 2021
Goodwill and Intangible Assets
Amortization of intangible assets		$ 3,100	$ 3,300			$ 9,446	$ 9,786
2021		12,600				12,600
2022		12,100				12,100
2023		11,900				11,900
2024 and 2025		11,000				11,000
Goodwill, impairment loss			0	$ 240,300		0
Indefinite-Lived Intangible Assets, Impairment			0			0
Indefinite-lived Trade names
Goodwill and Intangible Assets
Indefinite-Lived Intangible Assets, Impairment					$ 22,400
Indefinite-lived intangible assets, net carrying value		$ 15,400	$ 35,200			$ 15,400	$ 35,200	$ 15,400
Allen Edmonds
Goodwill and Intangible Assets
Intangible Assets, Impairment	$ 23,800
Allen Edmonds | Indefinite-lived Trade names
Goodwill and Intangible Assets
Indefinite-Lived Intangible Assets, Impairment	19,800				12,200
Allen Edmonds | Customer Relationships
Goodwill and Intangible Assets
Finite-lived intangible assets, impairment	$ 4,000
Via Spiga | Indefinite-lived Trade names
Goodwill and Intangible Assets
Indefinite-Lived Intangible Assets, Impairment					$ 10,200
Indefinite-lived intangible assets, net carrying value				$ 500
Indefinite-lived intangible assets, amortization period (in years)					2 years

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Goodwill and Intangible Assets (Details) - USD ($) $ in Thousands	Oct. 30, 2021	Jan. 30, 2021	Oct. 31, 2020
Goodwill and Intangible Assets
Intangible assets	$ 344,883	$ 344,883	$ 368,688
Accumulated amortization	(119,214)	(109,768)	(106,570)
Total intangible assets, net	225,669	235,115	262,118
Goodwill	4,956	4,956	4,956
Goodwill and intangible assets, net	230,625	240,071	267,074
Famous Footwear
Goodwill and Intangible Assets
Intangible assets	2,800	2,800	2,800
Brand Portfolio
Goodwill and Intangible Assets
Intangible assets	342,083	342,083	365,888
Goodwill	4,956	4,956	4,956
Goodwill, accumulated impairment charges	$ 415,700	$ 415,700	$ 415,700

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Finite and Infinite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	9 Months Ended		12 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Jan. 30, 2021	Aug. 01, 2020
Goodwill and Intangible Assets
Finite-Lived Intangible Assets, Accumulated Amortization	$ 119,214	$ 106,570	$ 109,768
Accumulated Impairment	106,205	82,400	106,205
Intangible assets, cost basis	451,088	451,088	451,088
Intangible Assets, Net Carrying Value	225,669	262,118	235,115
Indefinite-lived Trade names
Goodwill and Intangible Assets
Accumulated Impairment	92,000	72,200	92,000
Indefinite-Lived Intangible Assets, Cost Basis	107,400	107,400	107,400
Indefinite-lived intangible assets, net carrying value	15,400	35,200	15,400
Indefinite-lived Trade Names excluding Via Spiga Trademark
Goodwill and Intangible Assets
Indefinite-lived intangible assets, net carrying value	100
Tradenames
Goodwill and Intangible Assets
Finite-lived intangible assets, cost basis	299,488	299,488	299,488
Finite-Lived Intangible Assets, Accumulated Amortization	109,545	99,376	101,919
Accumulated Impairment	10,200	10,200	10,200
Finite-Lived Intangible Assets, Net Carrying Value	$ 179,743	$ 189,912	$ 187,369
Tradenames | Minimum
Goodwill and Intangible Assets
Finite-Lived Intangible Assets, Estimated Useful Life (Year)	2 years	2 years	2 years
Tradenames | Maximum
Goodwill and Intangible Assets
Finite-Lived Intangible Assets, Estimated Useful Life (Year)	40 years	40 years	40 years
Customer Relationships
Goodwill and Intangible Assets
Finite-lived intangible assets, cost basis	$ 44,200	$ 44,200	$ 44,200
Finite-Lived Intangible Assets, Accumulated Amortization	9,669	7,194	7,849
Accumulated Impairment	4,005		4,005
Finite-Lived Intangible Assets, Net Carrying Value	$ 30,526	$ 37,006	$ 32,346
Customer Relationships | Minimum
Goodwill and Intangible Assets
Finite-Lived Intangible Assets, Estimated Useful Life (Year)	15 years	15 years	15 years
Customer Relationships | Maximum
Goodwill and Intangible Assets
Finite-Lived Intangible Assets, Estimated Useful Life (Year)	16 years	16 years	16 years
Via Spiga | Indefinite-lived Trade names
Goodwill and Intangible Assets
Indefinite-lived intangible assets, net carrying value				$ 500

Leases (Details)

Leases (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021USD ($)	Oct. 31, 2020USD ($)	Oct. 30, 2021USD ($)location	Oct. 31, 2020USD ($)	Jan. 30, 2021USD ($)
Leases
Impairment of long-lived assets held-for-use	$ 1,111	$ 398	$ 3,399	$ 35,620
Right-of-use asset obtained in exchange for operating lease liability			77,700
Operating lease, right-of-use asset	500,308	601,574	$ 500,308	601,574	$ 554,303
Current Fiscal Year
Leases
Number of locations of Lease commitments not yet commenced in current fiscal year | location			2
Next Fiscal Year
Leases
Total operating lease liability	1,300		$ 1,300
Operating lease, right-of-use asset	1,300		1,300
Selling and Administrative Expenses
Leases
Lease concessions	100	1,700	1,700	3,700
COVID-19
Leases
Operating lease, impairment loss				21,100
Impairment of long-lived assets held-for-use				14,500
Retail Stores
Leases
Asset impairment charges	$ 1,100	$ 400	$ 3,400	$ 35,600

Leases - Components of Lease Ex

Leases - Components of Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Leases
Operating lease expense	$ 35,140	$ 38,568	$ 112,838	$ 124,906
Variable lease expense	10,982	12,739	30,985	36,090
Short-term lease expense	737	1,775	2,011	3,872
Sublease income	(419)	(29)	(477)	(76)
Total lease expense	$ 46,440	$ 53,053	$ 145,357	$ 164,792

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Leases
Cash paid for lease liabilities			$ 140,930	$ 99,517
Cash received from sublease income	$ 419	$ 29	$ 477	$ 76

Long-term and Short-term Fina_2

Long-term and Short-term Financing Arrangements (Details) - USD ($) $ in Thousands	Oct. 05, 2021	Aug. 16, 2021	Jan. 29, 2022	Oct. 30, 2021	Jan. 30, 2021	Oct. 31, 2020	Jul. 27, 2015
Long-term and Short-term Financing Arrangements
Debt instrument, interest rate, stated percentage							6.25%
Current portion of long-term debt				$ 99,598	$ 0	$ 0
Senior Notes Due 2023
Long-term and Short-term Financing Arrangements
Total senior notes							$ 200,000
Senior notes redemption price		100.00%
Current portion of long-term debt				$ 100,000
Principal amount of debt redeemed		$ 100,000
Senior notes, repurchase price, change of control				101.00%
Senior Notes Due 2023 | Subsequent Event
Long-term and Short-term Financing Arrangements
Principal amount of debt redeemed			$ 100,000
Revolving Credit Facility
Long-term and Short-term Financing Arrangements
Total long-term line of credit				$ 175,000
Letters of credit outstanding, amount				12,500
Line of credit facility, remaining borrowing capacity				$ 312,500
Revolving Credit Facility | Fifth Amendment to Fourth Amended and Restated Credit Agreement
Long-term and Short-term Financing Arrangements
Line of credit facility, maximum borrowing capacity	$ 500,000
Line of credit facility, option to increase, amount	250,000
Line of credit facility, decrease in maximum borrowing capacity	$ 100,000
Debt instrument, decrease in basis spread on variable rate	0.75%
Line of credit facility, excess availability, percent to trigger debt restrictions	10.00%
Line of credit facility, excess availability to trigger debt restrictions	$ 40,000
Line of credit facility, fixed charge coverage ratio to trigger debt restrictions	1.25
Minimum | Revolving Credit Facility | Fifth Amendment to Fourth Amended and Restated Credit Agreement
Long-term and Short-term Financing Arrangements
Debt instrument, basis spread on variable rate	0.00%

Shareholders' Equity (Details)

Shareholders' Equity (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Balance			$ (9,136)
Other comprehensive income, net of tax	$ 91	$ 334	648	$ 740
Balance	(8,471)	(31,184)	(8,471)	(31,184)
Canadian subsidiary
Increase in valuation allowance on deferred tax assets				500
Accumulated Foreign Currency Adjustment Attributable to Parent
Balance	(260)	(1,390)	(111)	(580)
Other comprehensive (loss) income before reclassifications	(257)	320	(406)	(490)
Other comprehensive income, net of tax	(257)	320	(406)	(490)
Balance	(517)	(1,070)	(517)	(1,070)
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent
Balance	(8,312)	(30,047)	(9,025)	(31,171)
Amounts reclassified from accumulated other comprehensive loss	445	(111)	1,340	1,393
Tax (benefit) provision	(87)	44	(269)	(336)
Net reclassifications	358	(67)	1,071	1,057
Other comprehensive income, net of tax	358	(67)	1,071	1,057
Balance	(7,954)	(30,114)	(7,954)	(30,114)
AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent
Balance				(92)
Other comprehensive (loss) income before reclassifications				87
Amounts reclassified from accumulated other comprehensive loss				6
Tax (benefit) provision				(1)
Net reclassifications				5
Other comprehensive income, net of tax				92
Accumulated Other Comprehensive (Loss) Income
Balance	(8,572)	(31,437)	(9,136)	(31,843)
Other comprehensive (loss) income before reclassifications	(257)	320	(406)	(403)
Amounts reclassified from accumulated other comprehensive loss	445	(111)	1,340	1,399
Tax (benefit) provision	(87)	44	(269)	(337)
Net reclassifications	358	(67)	1,071	1,062
Other comprehensive income, net of tax	101	253	665	659
Balance	$ (8,471)	$ (31,184)	$ (8,471)	$ (31,184)

Share-Based Compensation (Detai

Share-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Share-based Compensation
Share-based payment arrangement, expense	$ 3.4	$ 2.5	$ 8.8	$ 6.9
Share-based compensation arrangement by share-based payment award shares repurchased in period	(10,554)
Share-based compensation arrangement by share-based payment award shares issued in period		32,018	291,306	449,539
Long-term incentive awards granted during the period target value	$ 0		$ 6.5	$ 0
Long-term incentive awards granted during the period maximum value	$ 0		$ 13	$ 0
Long-term incentive award vesting period			3 years
Restricted Stock
Share-based Compensation
Granted, total number of restricted shares (in shares)	0	35,000	568,916	598,431
Granted (in dollars per share)		$ 9.73	$ 18.73	$ 6.14
Restricted Stock | Share-based Compensation Award, Cliff-vesting, Tranche One
Share-based Compensation
Share-based compensation arrangement by share-based payment award, award vesting period			1 year	1 year
Granted, total number of restricted shares (in shares)			4,910	12,748
Restricted Stock | Share-based Compensation Award, Graded-vesting
Share-based Compensation
Share-based compensation arrangement by share-based payment award, award vesting period		3 years	3 years	3 years
Granted, total number of restricted shares (in shares)			544,006	585,683
Restricted Stock | Share-based Compensation Award, Graded-vesting Tranche One
Share-based Compensation
Share-based compensation arrangement by share-based payment award, award vesting period		2 years	2 years	2 years
Share-based compensation arrangement by share-based payment award, performance percentage earned		50.00%	50.00%	50.00%
Restricted Stock | Share-based Compensation Award, Graded-vesting Tranche Two
Share-based Compensation
Share-based compensation arrangement by share-based payment award, award vesting period		3 years	3 years	3 years
Share-based compensation arrangement by share-based payment award, performance percentage earned		50.00%	50.00%	50.00%
Restricted Stock | Share-based Compensation Award, Cliff-vesting, Tranche Two
Share-based Compensation
Share-based compensation arrangement by share-based payment award, award vesting period			2 years
Granted, total number of restricted shares (in shares)			20,000
Performance Shares
Share-based Compensation
Share-based compensation arrangement by share-based payment award, award vesting period			3 years
Granted, total number of restricted shares (in shares)	0	87,750	175,500	87,750
Granted (in dollars per share)		$ 7.47	$ 18.63	$ 7.47
Performance Shares | Minimum
Share-based Compensation
Share-based compensation arrangement by share-based payment award, performance percentage earned			0.00%
Performance Shares | Maximum
Share-based Compensation
Share-based compensation arrangement by share-based payment award, performance percentage earned			200.00%
Restricted Stock Units (RSUs)
Share-based Compensation
Share-based compensation arrangement by share-based payment award, award vesting period			1 year
Restricted Stock Units (RSUs) | Non-employee Director
Share-based Compensation
Granted, total number of restricted shares (in shares)			44,180	118,150
Granted (in dollars per share)	$ 22.49	$ 9.78	$ 27.03	$ 10.01
Share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period, dividend equivalent	1,739	3,618	4,900	16,166

Share-Based Compensation - Rest

Share-Based Compensation - Restricted Stock Activity (Details) - Restricted Stock - $ / shares	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Share-based Compensation
Nonvested, total number of restricted shares (in shares)	1,380,246	1,360,602	1,397,227	1,271,795
Granted, total number of restricted shares (in shares)	0	35,000	568,916	598,431
Forfeited, total number of restricted shares (in shares)	(9,500)	(875)	(78,375)	(68,787)
Vested, total number of restricted shares (in shares)	(3,500)	(6,500)	(520,522)	(413,212)
Nonvested, total number of restricted shares (in shares)	1,367,246	1,388,227	1,367,246	1,388,227
Nonvested, weighted-average grant date fair value (in dollars per share)	$ 14.05	$ 17.81	$ 16.74	$ 26.77
Granted (in dollars per share)		9.73	18.73	6.14
Forfeited (in dollars per share)	15.72	14.51	15.48	23.11
Vested (in dollars per share)	26.42	25.18	26.26	28.23
Nonvested, weighted-average grant date fair value (in dollars per share)	$ 14.01	$ 17.57	$ 14.01	$ 17.57

Retirement and Other Benefit _3

Retirement and Other Benefit Plans - Components of Net Periodic Benefit Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Pension Plan
Retirement and Other Benefit Plans
Service cost	$ 1,872	$ 2,005	$ 5,615	$ 6,412
Interest cost	2,811	2,970	8,430	9,252
Expected return on assets	(7,108)	(8,330)	(21,331)	(23,205)
Actuarial loss (gain)	601	240	1,808	2,506
Prior service income	(129)	(324)	(386)	(1,031)
Settlement cost				222
Curtailment gain				(189)
Total net periodic benefit income	(1,953)	(3,439)	(5,864)	(6,033)
Other Postretirement Benefits Plan
Retirement and Other Benefit Plans
Service cost	0	0
Interest cost	8	10	28	31
Expected return on assets	0	0
Actuarial loss (gain)	(27)	(27)	(82)	(82)
Prior service income	0	0
Total net periodic benefit income	$ (19)	$ (17)	$ (54)	$ (51)

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Nov. 04, 2021	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation plan, maximum percentage of deferral of base salary		50.00%		50.00%
Deferred compensation plan, maximum percentage of deferral of annual incentive compensation		100.00%		100.00%
Fair value adjustments of mandatory purchase obligation		$ 1,900	$ 5,100	$ 15,424	$ 14,946
Long-lived assets, held and used		542,300	657,600	$ 542,300	657,600
Restricted Stock Units (RSUs)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Share-based compensation arrangement by share-based payment award, award vesting period				1 year
Blowfish, LLC
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value adjustments of mandatory purchase obligation		$ 1,900	$ 5,100	$ 15,400	$ 14,900
Blowfish, LLC | Subsequent Event
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Purchase obligation paid	$ 54,600

Fair Value Measurements - Asset

Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Jan. 30, 2021
Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis
Transfers into level 3	$ 0	$ 0
Transfers out of level 3	0	0
Fair Value, Recurring
Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis
Cash equivalents - money market funds	35,000	82,500	$ 45,000
Non-qualified deferred compensation plan assets	7,789	7,741	7,918
Non-qualified deferred compensation plan liabilities	(7,789)	(7,741)	(7,918)
Deferred compensation plan liabilities for non-employee directors	(1,764)	(813)	(989)
Restricted stock units for non-employee directors	(2,558)	(840)	(1,661)
Mandatory purchase obligation - Blowfish Malibu	(54,558)	(30,146)	(39,134)
Fair Value, Recurring | Fair Value, Inputs, Level 1
Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis
Cash equivalents - money market funds	35,000	82,500	45,000
Non-qualified deferred compensation plan assets	7,789	7,741	7,918
Non-qualified deferred compensation plan liabilities	(7,789)	(7,741)	(7,918)
Deferred compensation plan liabilities for non-employee directors	(1,764)	(813)	(989)
Restricted stock units for non-employee directors	(2,558)	(840)	(1,661)
Mandatory purchase obligation - Blowfish Malibu	0	0	0
Fair Value, Recurring | Fair Value, Inputs, Level 2
Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis
Cash equivalents - money market funds	0	0	0
Non-qualified deferred compensation plan assets	0	0	0
Non-qualified deferred compensation plan liabilities	0	0	0
Deferred compensation plan liabilities for non-employee directors	0	0	0
Restricted stock units for non-employee directors	0	0	0
Mandatory purchase obligation - Blowfish Malibu	0	0	0
Fair Value, Recurring | Fair Value, Inputs, Level 3
Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis
Cash equivalents - money market funds	0	0	0
Non-qualified deferred compensation plan assets	0	0	0
Non-qualified deferred compensation plan liabilities	0	0	0
Deferred compensation plan liabilities for non-employee directors	0	0	0
Restricted stock units for non-employee directors	0	0	0
Mandatory purchase obligation - Blowfish Malibu	$ (54,558)	$ (30,146)	$ (39,134)

Fair Value Measurements - Impai

Fair Value Measurements - Impairment Charges (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis
Total long-lived asset impairment charges	$ 1,111	$ 398	$ 3,399	$ 35,620
Famous Footwear | Selling and Administrative Expenses
Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis
Total long-lived asset impairment charges	400		1,200	14,896
Brand Portfolio | Selling and Administrative Expenses
Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis
Total long-lived asset impairment charges	$ 711	$ 398	$ 2,199	$ 20,724

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands		Oct. 30, 2021	Jan. 30, 2021	Oct. 31, 2020
Reported Value Measurement
Fair Value of Financial Instruments
Borrowings under revolving credit agreement	[1]	$ 175,000	$ 250,000	$ 300,000
Current portion of long-term debt	[1]	100,000
Long-term debt	[1]		200,000	200,000
Total debt	[1]	275,000	450,000	500,000
Estimate of Fair Value Measurement
Fair Value of Financial Instruments
Borrowings under revolving credit agreement		175,000	250,000	300,000
Current portion of long-term debt		100,000
Long-term debt			201,000	188,750
Total debt		$ 275,000	$ 451,000	$ 488,750
[1]	Excludes unamortized debt issuance costs and debt discount

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Income Taxes
Effective income tax rate reconciliation percent	24.90%	(1.90%)	27.70%	19.80%
Deferred taxes			$ 0

Commitments and Contingencies (

Commitments and Contingencies (Details) - Redfield Site - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Oct. 30, 2021	Jan. 29, 2022
Commitments and Contingencies
Cumulative environmental remediation expense	$ 32.3
Environmental exit costs, assets previously disposed, liability for remediation	9.9
Reserve for anticipated future remediation activities for off site remediation	5.1
Reserve for anticipated future remediation activities for on site remediation	$ 4.8
Accrual for environmental loss contingencies, discount rate	4.80%
Accrual for environmental loss contingencies, gross, total	$ 13.7
Environmental loss contingencies, undiscounted, current year		$ 0.6
Accrual for environmental loss contingencies, undiscounted, first year	0.1
Accrual for environmental loss contingencies, undiscounted, second year	0.1
Accrual for environmental loss contingencies, undiscounted, third year	0.1
Accrual for environmental loss contingencies, undiscounted, fourth year	0.1
Accrual for environmental loss contingencies, undiscounted, after fourth year	12.7
Other Noncurrent Liabilities
Commitments and Contingencies
Environmental exit costs, assets previously disposed, liability for remediation	8.9
Other Accrued Expenses
Commitments and Contingencies
Environmental exit costs, assets previously disposed, liability for remediation	$ 1